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INTERACTIONS OF DIPLOID EMBRYONAL CARCINOMA CELLS AND NORMAL INNER CELL MASS 
CELLS WITH 2.5 DAY MOUSE EMBRYOS FOLLOWING AGGREGATION 
ABSTRACT 
Spontaneous teratocarcinomas are ovarian or testicular tumors which have 
their origins in germ cells. The tumors contain a disorganized array of benign 
differentiated cells as well as an undifferentiated population of malignant 
stem cells, the embryonal carcinoma or EC cells. These pluripotent stem cells 
in tissue culture share many properties with the transient pluripotent cells of 
the early embryo, and might therefore serve as models for the investigation of 
developmental events ill vitro. 
The property of EC cells of prime interest in this study is an in vivo 
phenomenon. Certain EC cell lines are known to be regulated ill vivo and to 
differentiate normally in association with normal embryonic cells, resulting in 
chimeric mice. These mice have two genetically distinct cell populations, one 
of which is derived from the originally malignant EC cells. This has usually 
been accomplished by injection of the EC cells into the Day 3 blastocyst. In 
this study, the interactions between earlier stage embryos and EC cells have 
been tested by aggregating clumps of EC cells with Day 2 embryos. The few 
previous aggregation studies produced a high degree of abnormality in chimeric 
embryos, but the EC cells employed had known chromosomal abnormalities. In this 
study, two diploid EC cell lines (P19 and Pi0) were aggregated with 2.5 day 
mouse embryos, and were found to behave quite differently in the embryonic 
environment. P19 containing aggregates generally resorbed early, and the few 
embryos recovered at midgestation were normal and non-chimeric. Pi0 containing 
aggregates survived in high numbers to midgestation, and the Pi0 cells were very 
successful in colonizing the embryo. All these embryos were chimeric, and the 
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contribution by the EC cells to each chimera was very high. However, these 
heavily chimeric embryos were all abnormal. 
Blastocyst injection had previously produced some abnormal embryos with 
high Pl0 contributions in addition to the live born mice, which had lower EC 
contributions. This study now adds more support to the hypothesis that high EC 
contributions may be incompatible with normal development. The possibility that 
the abnormalities were due to the mixing of temporally asynchronous embryonic 
cell types in the aggregates was tested by aggregating normal pluripotent cells 
taken from 3.5 day embryos with 2.5 day embryos. Early embryo loss was very 
high, and histological studies showed that the majority of these embryos died by 
6.5 days development. Some embryos escaped this early death such that some 
healthy chimeras were recovered, in contrast to recovery of abnormal chimeric 
embryos following Pl0-morula aggregations, and non-chimeric embryos following 
P19-morula aggregations. 
This somewhat surprising adverse effect on development following 
aggregation of normal cell types suggests that there are developmental 
difficulties associated with the mixing of asynchronous cell types in 
aggregates. However, the greater magnitude of the adverse effects when the 
aggregates contained tumor derived cells suggests that EC cells should not be 
considered the complete equivalent of the pluripotent cells of the early 
embryo. 
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INTRODUCTION 
THE QUESTIONS RAISED IN THIS STUDY 
The phenomenon of regulation and participation in normal 
development by cultured EC cells upon their return to the 
embryonic envirnonment is of particular interest in this study. 
The P10 and P19 cell lines seemed to be ideal candidates 
as EC cell lines which could be used to explore more completely 
the effects of aggregating EC cells with morulae. They are 
euploid and their response to the embryonic environment 
following blastocyst injection has been fully explored. 
It was hoped that by aggregating these cells with early morulae 
chimeras might be generated at an even higher frequency and that 
the EC cells would predominate in at least some of the chimeras 
such that the in vivo developmental potential of euploid EC 
cells could be mo~e completely assessed. 
The following questions are considered in this study. 
1. Aggregation is an efficient technique for producing 
EC-embryo chimeras, but apparently produces a high 
level of abnormality. Is there really a difference in 
the rate of abnormal development produced by aggregation 
compared to blastocyst injection? 
2. If so, does a high rate of abnormality correlate with 
higher EC contributions achieved in aggregation chimerast 
3. Alternatively, are there developmental problems 
associated with mismatching of cells from different 
developmental stages? If so, ICM-morula aggregates 
would also be expected to show abnormalities of 
development. 
4. Can an improvement in the developmental performance 
of an EC cell line be induced by a pretreatment of 
EC cells with retinoic acid? If so, P19 cells, 
which seem to persist to some degree as stem cells 
in all chimeras, might be committed to differentiation 
and more normal development as a result of retinoic 
acid pretreatment. 
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LITERATURE SURVEY 
EARLY DEVELOPMENT OF MOUSE EMBRYOS 
A preliminary overview 
One very broad division of mammalian development is into pre-implantation 
and post-implantation stages. In the pre-implantation stage, the free living 
embryo is most accessible to experimental manipulation, whereas following 
implantation such manipulations become very much more difficult. Fortunately, 
critical developmental events take place before implantation and the study of 
these events is pertinent to central issues of cellular differentiation and 
development. 
In this study, two pre-implantation stages of development are of particular 
interest: the 2.5 day morula and the 3.5 day blastocyst. It will be useful to 
begin, therefore, with an overview of the early development of mouse embryos, in 
order to define these two pre-implantation embryo stages, and to describe the 
events preceding and immediately following their formation. 
In their 1966 description of the early embryology of the mouse, Snell and 
Stevens present a comprehensive review of pre-implantation development which has 
been used extensively in the preparation of this overview. 
A female in estrus will ovulate as many as 15 to 20 eggs. Each egg is 
enclosed within a transparent zona pellucida, a mucoprotein produced by the 
surrounding ovarian follicular cells. The zonae must be removed from 
pre-implantation embryos prior to experimental manipulations, and Mintz (1962) 
noted that embryos become "sticky" following liberation from the zonae. 
She suggested that in addition to one proposed function of the zona, which is to 
assist retention of the relatively loosely associated cells during the early 
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cleavage divisions, the zonae might serve to prevent natural aggregation of 
cleavage stage embryos. 
A female in estrus becomes receptive to mating about 2 hours prior to 
ovulation such that sperm are present in the upper reaches of the oviducts at 
the time of ovulation, and fertilization occurs almost immediately. However, 
the first cleavage division does not occur until about 24 hours later. Mating 
occurs during the dark cycle, and due to the delay before first cleavage, single 
cell embryos can be recovered on the first morning after mating. By a widely 
accepted, though not universal convention, the day on which the vaginal plug is 
found is referred to as Day 0.5 of mouse pregnancy. 
On Day 1 of pregnancy, 2-cell embryos can be recovered from the oviducts, 
and the pace of the cleavage divisions then increases, with the divisions 
remaining nearly synchronous. By early morning of Day 2 of pregnancy, 8-cell 
embryos can be recovered from the oviducts. Because cleavage involves cell 
divisions without growth, this embryo is the same size as the egg. The process 
of compaction begins at the 8-cell stage. During compaction, the cell outlines 
are lost as the cells flatten against one another and establish cell-cell 
communications via gap junction formation (Goodall and Johnson, 1984). From 
this stage onwards the embryo is known as a morula. At about the 32-cell stage, 
a cavity begins to form within the morula. This cavity expands rapidly, such 
that by Day 3 of pregnancy, the hollow, fluid-filled structure known as the 
blastocyst has developed. The blastocyst represents a landmark stage in 
development because the first differentiation of cell types occurs during its 
formation. The blastocyst consists of two cell types: firstly, a single layer 
of cells known as the trophectoderm surrounding the blastocoelic cavity. Some 
of the cells of the trophectoderm will go on to form the fetal portion of the 
placenta (Gardner, ~t al., 1973). Secondly, within this cavity, at one pole, 
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there is a small cluster of cells known as the inner cell mass (rCM). At the 
64-cell stage, the reM consists of about 15 cells, some of which are destined to 
form the extraembryonic membranes and a few, perhaps as few as three cells in 
the early blastocyst (Markert and Petters, 1978) are destined to become the 
embryo proper. 
During the early cleavage divisions the embryos move through the oviducts, 
and at about the time of cavitation, the morulae enter the uterus. Blastocyst 
formation then occurs within the uterus. The blastocysts are still enclosed 
within their zonae, and are still the size of the egg. By Day 4 of pregnancy, 
the mature blastocysts hatch from their zonae and implant within the bicornuate 
uterus. The blastocysts implant in uterine crypts and the uterine epithelium in 
the region degenerates and is sloughed off. At the same time, there is a 
proliferation of endometrial stromal cells giving rise to the maternal deciduum 
(reviewed by Kearns and Lala, 1983) such that by Day 5, a visible swelling is 
present in the uterus at each implantation site. The pre-implantation 
development of mouse embryos is summarized diagrammatically in Figure 1. 
Rapid growth of the embryo begins with implantation. Further cell 
differentiations occur by the late blastocyst stage such that the rCM at 
implantation consists of primitive endoderm (the outer layer) and primitive 
ectoderm (the inner cells) (Sherman,1977). By Day 6, the structure known as the 
egg cylinder has developed. During egg cylinder formation, a layer of primitive 
endoderm cells spreads over the inner surface of the trophectoderm forming the 
parietal endoderm layer. A second layer of primitive endoderm, known as 
visceral endoderm, surrounds the embryonic ectoderm of the egg cylinder. The 
embryonic ectoderm will eventually give rise to the three germ layers of the 
embryo (that is, embryonic ectoderm, endoderm and mesoderm) (Gardner and 
Rossant, 1979). There is also a proliferation of the polar trophectoderm cells 
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overlying the ICM, givipg rise to the ectoplacental cone (epc) (Copp, 1979). 
This is an invasive tissue, invading the maternal deciduum. The resultant 
hemorrhage and pooling of blood around the epc cells probably establishes an 
early nourishment of the embryo, and the epc eventually forms part of the 
placenta. The mural trophectoderm cells begin the transformation to giant 
cells, via endoreduplication of their DNA (Copp,1978). Between the epc and the 
embryonic ectoderm lies the remaining tissue type found in the 6 day egg 
cylinder, the extraembryonic ectoderm (also surrounded by visceral endoderm). 
This tissue is also derived from the trophectoderm, and will give rise to the 
chorionic ectoderm, another placental component (Rossant and Lis, 1979a; 
Rossant, ~ lLl., 1983). This early post-implantation development is diagrammed 
in Figure 2. 
Cell fate is determined by descriptive studies and cell lineage studies. 
Such studies have produced the plan of cell lineage relationships in early mouse 
embryogenesis diagrammed in Figure 3 (Rossant and Papaioannou, 1977). Cell 
lineage studies have made extensive us~ of experimental chimeras. 
Chimeras in embryological studies 
In Greek mythology, the chimera was the monster reputed to have the head of 
a lion, the body of a goat, and the tail of a serpent or dragon (Larousse,1966). 
In modern biological usage the term chimera is used to describe an animal which 
is a special type of genetic mosaic. Mosaics are animals in which two or more 
genetically distinct populations of cells co-exist. In a chimera, the two 
populations of cells have their origins in different animals. Chimeras do occur 
naturally in a variety of mammalian species, arising usually by placental 
vascular connections and cell mixing during twin pregnancy (Gardner,1968) but 
chimeras are most often a product of experimental manipulation. 
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In 1961, Tarkowski first reported the production of mouse chimeras 
following aggregation of 8-cell embryos and Mintz (1962, 1964) refined the 
technique for aggregating early morulae. In these studies the critera used for 
judging chimerism in the offspring was the production of inters exes and coat 
color mosaicism. Chapman ~ ale (1972) developed a valuable enzyme marker 
system such that chimeras began to be used as tools for investigations into 
various developmental questions. The enzyme glucose phosphate isomerase is a 
dimeric enzyme which is a very useful marker due to its widespread tissue 
distribution and the existence of electrophoretically variant forms (Carter and 
Parr, 1967). Homozygotes (Gpi-1b/Gpi-1b or Gpi-1a/Gpi-1a) produce either the 
faster migrating BB form of the enzyme or the slower migrating AA form. 
Heterozygotes (Gpi-1a/Gpi-1b) produce both AA and BB enzyme molecules in each 
cell as well as a hybrid form of the enzyme consisting of one A subunit and one 
B subunit. A chimera, made by aggregating a homozygous Gpi-1a/Gpi-1a embryo 
with a homozygous Gpi-1b/Gpi-1b embryo, will have two populations of cells, one 
producing AA enzyme molecules and the other producing BB molecules. AB enzyme 
molecules would not be found in any tissue samples from such a chimera unless 
cell fusion had occurred during development of that tissue. GPI is now widely 
used as the marker enzyme for detecting two cell populations in presumptive 
chimeras in many studies. 
As Markert and Petters (1978) point out, thousands of healthy chimeric mice 
have now been produced. At the time of their study, the chimeras had all been 
derived from two embryos, and they then reported production of chimeras from 
aggregations of three 8-cell embryos. One triple chimera, with black, white, 
and yellow patches in its coat was produced from these aggregations (as well as 
offspring with mixtures of two coat colours, and single coat colours) indicating 
that at least three cells of the ICM had participated in development of the 
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embryo proper. They next went on to show that four 8-cell embryos could be 
aggregated with successful development of octaparental mice (Petters and 
Markert, 1980). 
Development has been completely successful then, following aggregations of 
as many as four embryos with each other at the 4-cell stage, the 8-cell stage, 
or at the early morula stage. Although the aggregate morulae, and the 
blastocysts which develop from them are notably larger than normal embryos at 
these stages, the chimeric offspring are not giant mice, but are of normal size. 
Aggregate embryos are thus capable of size regulation. Lewis and Rossant (1982) 
demonstrated that this regulation occurred between 5.5 and 6.5 days development; 
that is, shortly after egg cylinder development. Aggregations between 2.5 day 
morulae and 3.5 or 4.5 day ICMs have also been successful and were the first 
proven cases of chimeras made through the association of cell types from two 
distinctly different stages of development (Rossant, 1975; Rossant and Lis, 
1979a and b). 
While the aggregation technique for producing chimeras has its place in 
developmental studies, a second, more sophisticated technique for producing 
chimeras early in embryogenesis has been developed. Gardner (1968) used a 
micromanipulator assembly to inject embryonic cells into the blastocoelic cavity 
of 3.5 day embryos. While this was a more difficult technique than aggregation, 
it allowed studies of a more precise nature, in which fewer cells were added to 
embryos or cells from a wide variety of developmental stages were mixed. 
Successful chimera production following blastocyst injection in experiments such 
as one (Gardner and Rossant, 1979) in which extraembryonic endoderm cells from 5 
and 6 day embryos were injected into 3.5 day embryos indicate that the 
blastocyst can exert a regulatory effect over added cells also, even when a 
considerable degree of temporal asynchrony exists (Rossant, ~al., 1978). An 
24 
even more remarkable example of regulation by the blastocyst will now be 
considered. 
Cells from cell lines derived from malignant tumors have been injected 
into blastocysts. In some cases, regulation of the tumor derived cells occurred 
within the embryonic environment such that healthy, tumor free animals were 
born. Coat and eye pigmentation present in these animals readily indicated 
chimerism. That is, the originally malignant cells had been switched to normal 
pathways of differentiation through their association with the normal embryonic 
cells within the uterine environment. The tumors from which the cell lines were 
derived are known as teratocarcinomas, and the normalisation of these tumor 
derived cells is of prime interest in this study. 
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TERATOCARCINOMAS AND PROPERTIES OF EMBRYONAL CARCINOMA CELLS 
Origins of teratocarcinomas 
Spontaneous teratocarcinomas are tumors which have their origins in germ 
cells. These tumors were reported in the ovaries or testes of humans in the 
19th century, and have long been intriguing as they characteristically contain 
an array of differentiated cell types. The tumors routinely contain tissues 
derived from all three embryonic germ layers. Illmensee and Stevens (1979), for 
example, display a photomicrograph of a sectioned tumor in which cartilage, 
bone with marrow, adipose tissue and muscle fibres, all of mesodermal origin, as 
well as neural tissue from ectoderm and glandular epithelium from endoderm have 
been identified. Additionally, in humans the tumors can contain such organized 
structures as hair and teeth. As gruesome as these tumors sound, if they 
contain only these differentiated cell types, they are benign and are known as 
teratomas. A teratocarcinoma is a malignant tumor however, with the potential 
for continued growth and metastasis in humans. (In the earlier literature, a 
teratomatous tumor is referred to as a teratoma, without distinguishing between 
those which were benign and those which were malignant.) The malignancy of 
these tumors is due to retention of an undifferentiated, proliferating 
population of stem cells, known as the embryonal carcinoma cells (reviewed by 
Illmensee and Stevens, 1979 and Martin, 1980). Because these cells have the 
potential to differentiate into a variety of cell types, they are referred to as 
multipotent or pluripotent cells. In this regard, they are similar to certain 
of the cells of the early mouse embryo. 
It was largely the work of Leroy Stevens in the 1950s and 1960s which 
established the origins of teratocarcinomas. In 1953, Stevens noted testicular 
teratomas in mice of strain 129. The tumors arose early and could be found in 
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the fetuses by Day 15. They were localized exclusively in the seminiferous 
tubules of the testis, which contain the primordial germ cells. At this early 
stage, the fetal tumors in these tubules resembled 5 day embryos; that is, early 
egg cylinders. It seemed possible that the tumors might have arisen from the 
germ cell precursors which are set aside early in development (by Day 8) and 
which have migrated to the fetal genital ridges by Day 12. Indeed, when male 
genital ridges were grafted to the testes of histocompatible adult males a high 
incidence of grafts became teratomas. Finally, the germ cell origin of these 
tumors was firmly established by genetic manipulations, employing the mutant 
known as steel. Mice homozygous for steel completely lack germ cells. This 
mutation was introduced into the strain 129 subline with the high incidence of 
spontaneous tumors and recipients of homozygous steel genital ridges did not 
develop the tumors (reviewed in Illmensee and Stevens, 1979). 
The marked similarity of the fetal tumors in the strain 129 seminiferous 
tubules to an early embryo suggested to Stevens that the tumors might also be 
inducible by grafting early embryos to ectopic (extrauterine) sites. He 
initially grafted 2-cell embryos to histocompatible adult testes and later 
(Stevens, 1969) grafted blastocysts and 6 day egg cylinders. Following grafting 
he observed normal embryonic development at the graft site for about one week. 
Then the grafts became disorganized and a small proportion eventually grew into 
typical teratomatous tumors. Those tumors retained an undifferentiated stem 
cell population and were readily transplantable from one host to another, such 
that they could be maintained long past the time when they would kill their 
original host. Stevens designated these induced, transplantable teratomatous 
tumors OTT. 
From his work Stevens concluded that teratocarcinomas can arise either from 
germ cells in the fetal genital ridges, or from pluripotent cells in the early 
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embryo. As shown in Figure 4, embryos grafted at 5 through 7 days gestation (at 
the early egg cylinder stage especially) are particularly efficient at producing 
teratocarcinomas. By Day 8, a growth of differentiated tissues usually results 
which does not contain undifferentiated cells (Stevens, 1970). Then, at 11 days 
through 13 days gestation, grafts of male fetal genital ridges produce 
teratocarcinomas at a high frequency, but beyond 13 days, the incidence of the 
tumors falls off sharply. This is thought to be the result of a maturation of 
the primordial germ cells which prevents their continued tumor production 
(Illmensee and Stevens, 1979). 
Just as Stevens had noted an increased incidence of testicular teratomas in 
male mice of strain 129, he eventually found a strain of mice with a high 
incidence of ovarian teratomas (Stevens and Varnum, 1974). Some of the eggs in 
the ovaries of these mice were behaving as if they had been fertilized and were 
undergoing the initial steps of normal embryogenesis. Most of these apparently 
died before primary germ layer formation. However, some progressed in an 
organized fashion through the blastocyst stage to the early egg cylinder stage, 
with recognizable endoderm and ectoderm layers. At this point the growths 
became disorganized. The tumors seen were classical teratomas with cartilage, 
bone, adipose tissue, hair, and so on. 
In summary, Stevens and Varnum (1974) point out that 4 sources of 
teratomatous tumors were now known in mice. These are: 
1. spontaneous testicular tumors, arising from the primordial germ cells 
in the seminiferous tubules 
2. spontaneous ovarian tumors, arising from parthenogenetic activation 
of oocytes within mature ovaries 
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3. experimentally induced tumors, arising from grafting 11 to 13 day male 
fetal genital ridges, containing germ cells, to various sites, 
especially the testis 
4. expetimentally induced tumors, arising from grafting male or female 
early egg cylinders, containing pluripotent embryonic cells, to ectopic 
sites. 
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Experimental teratomas are induced by grafting an early embryo 
or the genital ridge of a fetus to an extrauterine site in an 
adult mouse. A 6 day embryo or an 11 to 13 day genital ridge 
5 
is most likely to produce a teratoma. (Illmensee and Stevens, 1979) 
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Properties of embryonal carcinoma cells 
The embryonal carcinoma cells are the undifferentiated, proliferating stem 
cells which confer malignancy on the teratomatous tumors in which they persist. 
These stem cells make serial transplantation of the tumors possible, and a 
number of cultured EC cell lines have now been established from various 
transplantable tumors. 
The embryonic counterpart of EC cells 
Martin (1980) has given some consideration to the normal embryonic 
equivalent of EC cells. The rCM of the pre-implantation embryo consists of 
pluripotent cells. At the time of the first differentiation of the rCM cells, 
two cell types arise: the pluripotent primary ectoderm which will give rise to 
the fetus, and extraembryonic endoderm of limited potential (Gardner and 
Rossant, 1979). In vitro, when EC cells form embryoid bodies, they give rise to 
an outer layer of endodermal cells which surround the EC core. This observation 
suggests that EC cells might most closely resemble the cells of the rCM of the 
early embryo (Martin, 1975; Martin and Evans, 1975; Martin, ~ ~., 1977). 
However, a report by Diwan and Stevens (cited by Martin, ~ al., 1978) that 
isolated embryonic ectoderm grafted to an extrauterine site will itself give 
rise to a teratocarcinoma suggested that EC cells might actually correspond most 
closely to the primary ectoderm. Accordingly, Martin, e1 al.(1978) compared the 
protein synthesis patterns in morulae to that of blastocysts, or their rCMs, to 
the pattern seen in EC cells. Differences in the electrophoretic profiles of 
~5~met labelled proteins were seen between 8-cell and later stage embryos. The 
EC profile differed markedly from the pattern seen in cleavage stage embryos and 
showed greatest similarity to the isolated rCM profile, although it contained a 
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band missing from the ICM profile. The profiles from later ICMs closely matched 
the EC cell profile, including the previously missing band. It was the profile 
from the isolated embryonic ectoderm from these ICMs which contained the band 
characteristic to several EC cell lines, and therefore Martin and her colleagues 
have concluded that EC cells might be most closely analogous to the pluripotent 
embryonic ectoderm cells of the early post-implantation ICM. This is probably 
now the most widely accepted view. 
III ~ behavior of EC cells: The induction of differentiation by retinoic acid 
EC cells may be valuable substitutes for embryonic cells in in ~ 
investigations of a variety of developmental events. Mention of the ability of 
EC cells to differentiate spontaneously in ~ has already been made. In 
suspension culture, aggregates differentiate into the embryoid bodies 
investigated by Martin, amongst others. Additionally, differentiation of EC 
cells can be induced in vitro by various chemical inducers, particularly 
retinoic acid. 
Retinoic acid is a vitamin A derivative. Its structure is shown in Figure 
5. Vitamin A is known to have many biological effects, defined largely by 
nutritional deprivation studies, which include effects on growth and fertility, 
and on the normal development of skin, epithelia, teeth and bones. While 
essential to good health, vitamin A in excessive amounts is known to have toxic 
properties, and is a potent teratogenic agent (Hogan, 1979). 
Aware of the effects of retinoic acid on epithelial tissues, and on various 
tissue remodelling processes (Wilson and Reich, 1978; Strickland and Mahdavi, 
1978) Strickland and Mahdavi asked if retinoids might promote the 
differentiation of EC cells i]Lv11Eo. They tested the effect of retinoic acid 
on F9 cells, an EC cell line which undergoes very limited differentiation 
normally. In response to 10-7M RA, morphological changes were seen in the F9 
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FIGURE 5 
Basic structural formula of retinoids 
R 
R= -CH20H: parent substance: trans-vitamin A alcohol 
R= -CHO: trans-retinal (vitamin A aldehyde) 
R= -COOH: trans-retinoic acid (vitamin A acid) 
JJ 
cultures within 24 hours, and eventually the cultures contained large flat cells 
closely resembling the presumptive endoderm derived from embryoid bodies. 
not 
P19 is another EC cell line which doesAr eadily differentiate in vitro. The 
only differentiated cells to appear spontaneously resemble extraembryonic 
endoderm cells, and stem cells always persist even when these cells appear. 
More extensive differentiation of P19 cells was initially induced by 
dimethylsulfoxide (DMSO). Differentiation of cells in response to DMSO was 
first noted in 1971 by Friend and her coworkers when cells of a tissue cultured 
line of mouse virus-induced erythroleukemic cells in medium containing 2% DMSO 
differentiated and began secreting hemoglobin. McBurney found that P19 cells 
also differentiate in response to DMSO (McBurney, ~ ~., 1982). When P19 
aggregates were exposed to DMSO in suspension cultures for 4 to 5 days and 
then plated out, differentiation became apparent within 2 days. The cultures 
contained contracting muscle cells and fibroblast-like cells. The muscle cells 
in DMSO treated cultures contained muscle specific myosin, identified in an 
immunofluorescence assay (Edwards, g! gl., 1983). 
If the P19 aggregates were exposed instead to retinoic acid for 5 days they 
differentiated into neurones and glial cells. Jones-Villeneuve, et al. (1982) 
determined that the differentiation of P19 cells into neuronal cells was 
dependent on the retinoic acid concentration. At concentrations greater than 
-9 5x10 M for at least 24 hours before plating all cultures contained cells with 
neuron-like processes by 72 hours after plating. Immunofluorescence assays have 
confirmed the presence of neurofilament protein, and elevated levels of choline 
acetyl transferase and acetylcholinesterase have also been found in the RA 
treated cultures containing presumptive neuronal cells (Jones-Villeneuve et al., 
1983). 
McBurney's emphasis has been directed towards determining RA treatment 
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conditions which promote differentiation of P19 cells along specific routes. In 
assessing the response of cultures to various concentrations of the drug for 
various times, he has recorded the appearance of neuron-like cells, for example, 
in aggregate outgrowths. However, confirmation of persistence of 
undifferentiated EC cells, despite differentiation of other cell types may be of 
considerable importance in other types of experiments. 
Solter and Knowles produced a monoclonal antibody in response to 
immunization of a mouse with EC cells which reacted with an antigen present on 
undifferentiated EC cells, but not on their differentiated derivatives (Solter 
and Knowles, 1978; Solter, ~ al., 1978). Embryos from various stages were 
tested for reactivity, and antibody was not bound to unfertilized eggs, single, 
2 or 4-cell embryos. Eight-cell embryos began to express the antigen, while 
morulae and ICMs from blastocysts bound the antibody quite efficiently. This 
monoclonal antibody is specific, therefore, for an antigenic determinant present 
on EC stem cells and on embryonic cells from specific stages. Solter designated 
this antigen stage-specific embryonic antigen 1 (SSEA-1) and potentially it 
could serve as a marker for undifferentiated EC cells persisting in RA treated 
cultures. 
McBurney has recently employed a similar antibody to monitor loss of stem 
cells from his cultures. The monoclonal antibody AECAl-9 appears to detect an 
antigen closely related to the antigen detected by the antibody to SSEA-1 
(Harris, ~ ~., submitted for publication). An indirect immunofluorescence 
assay demonstrated that 2 days after plating treated aggregates a very high 
level of antigen expression is evident (Jones-Villeneuve, ~ ~l., 1983) 
indicating initial persistence of undifferentiated stem cells in retinoic acid 
treated cultures. 
As McBurney points out, (McBurney, g! al., 1983) DMSO is of no 
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physiological significance. It may exert its influence through various rather 
non-specific solubilizing effects. But retinoids are naturally occurring. In a 
study into possible mechanisms of action of RA, Jetten and Jetten (1979) were 
able to demonstrate the presence of a cytoplasmic binding protein for RA in 
various EC cell lines. The existence of binding protein is shown through 
binding of [&H}retinoic acid to a protein component by a cytosolic supernatant 
from the EC cells. The supernatant from the nuclear fraction did not bind 
@~RA, but in cells which had been preincubated with~~RA the nuclear fraction 
was found to contain~H}RA. Thus, it was postulated that RA must first be bound 
to a cytoplasmic binding protein and that this complex is transported to the 
nucleus, a model reminiscent of the proposed mechanism for transport of steroid 
hormone-receptor complexes to the nucleus. These complexes are then thought to 
interact in some way with chromatin. 
Schindler, Matthei and Sherman (1981) isolated two mutant clones which did 
not respond to RA, and their data suggest that the failure to differentiate was 
due to a lack of binding of the RA to a cytoplasmic RA binding protein (cRABP). 
Therefore, this complexing of RA to cRABP is likely an essential step in the 
sequence leading to RA induced differentiation of EC cells. 
How might retinoic acid bring about differentiation of different cell 
types in a developing embryo? McBurney has suggested that an RA concentration 
gradient might playa role. In the initial experiments in which P19 cells were 
treated with retinoic acid, cardiac muscle was rarely observed and skeletal 
myoblasts were never seen. Rather, these cultures contained cells of the 
neuronal lineage. But when much lower doses of RA were used, they were able to 
show that the differentiated cell types formed were dependent on the RA 
concentration used. At 10-~M RA, an abundance of cardiac muscle was seen, while 
·t 
at 10 M skeletal muscle predominated, and neurones and astroglia appeared at 
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- 7 10 M RA. In contrast to the first low dose studies these cells were cultured 
for many days after treatment with the low RA doses to see the effects, and 
large numbers of undifferentiated cells persisted for some time in these low 
dose cultures (Edwards and McBurney, 1983). McBurney has suggested an 
hypothesis based on these results which proposes that "gradients of retinoids 
may play some role in the developmental decisions taken by these embryonic 
cells" (McBurney, ru; V., 1983). 
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Participation by EC cells in normal differentiation in chimeras 
EC cells, originating from the pluripotent cells of the embryonic 
ectoderm of the early egg cylinder, appear to retain many similarities with 
these cells of the early embryo, as judged by their ability to undergo 
differentiation to a wide variety of cell types in~. However, the ultimate 
test of normality of EC cells would be the demonstration of the ability of these 
cells to participate in normal development in a chimera. 
In 1974, Brinster reported the recovery of one chimera (judged by coat 
pigmentation only) following injection of cells from embryoid bodies into 
blastocysts (Brinster, 1975). This was the first demonstration that the 
malignancy of the stem cells could be reversed. In 1975, Mintz and Illmensee 
reported a more detailed study into the properties of the cells within embryoid 
bodies of OTT 6050. Core cells were injected into blastocysts and they reported 
recovery of chimeras, at a low frequency, which were tumor free and demonstrated 
chimerism throughout a wide variety of tissues. 
Meanwhile, attempts were underway to establish in ~ tissue cultured 
cell lines from the teratocarcinomas maintained as in Yix2 transplantable 
tumors. For example, Lehman, et al. (1974) used cell suspensions from embryoid 
bodies from the same OTT 6050 tumor to initiate tissue cultures. The primary 
cultures consisted of two cell types: flat epithelial cells and dense 
colonies of cells. Within a few days additional cell types could be seen while 
the dense colonies persisted. These dense colonies contained cells of identical 
morphology to the cells of the embryoid body cores, and were assumed to be the 
EC cells. These cells, after cloning and subcutaneous injection into mice, gave 
rise to typical teratocarcinomas while the differentiated cells did not. 
One possible application of cultured EC cells was in establishing animal 
models for human disease. The Lesch-Nyhan syndrome in humans is characterized 
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by severe neurological symptoms as well as other problems. It is the result of 
a deficiency of the X-linked gene for hypoxanthine phosphoribosyl transferase 
(HPRT). While the HPRT gene is also X-linked in the mouse, HPRT- mice have not 
been found, and in fact no animal model exists for Lesch-Nyhan syndrome. Dewey, 
et ale (1977) attempted to introduce the defective gene into mice using HPRT- EC 
cells as the vehicle. While chimeras were produced in which HPRT- cells made up 
a sizeable fraction of certain tissues (which showed lower than non-chimeric 
control enzyme levels) no animal showed any disease symptoms. The EC cells used 
were XO and trisomic for chromosome 6, and were unlikely to colonize the germ 
line. This occurrence of karyotypic abnormalities in cultured EC cell lines is 
a recurring problem. 
Papaioannou and her co-workers also tested the developmental potential of 
various cultured EC cells in blastocyst injection experiments (Papaioannou, ~ 
al., 1975, 1978). They found that the rate of chimera production was very low, 
and tumors were found in most of the chimeric offspring while the contribution 
by the EC cells to normal tissues was sporadic and very limited, usually 
restricted to trace amounts only. Karyotypic abnormalities were detected in all 
the cell lines used in this study, and these abnormalities may have affected the 
capacity of the cells to participate in normal embryogenesis. 
Both these groups saw the establishment of EC cell lines with normal 
karyotypes as an important next step in assessing the ability of these cells to 
participate in normal development (Cronmiller and Mintz, 1978). The validity of 
using cultured EC cells as ill Yilr2 models for various aspects of 
embryogenesis, as well as their potential use as carriers of selected mutations 
into mouse strains was rather dependent on a demonstration of a complete 
recovery of normal function ig vivo (Papaioannou, ~ ~., 1978). 
Performance of diploid EC cell lines 
The METT-l EC cell line 
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In 1981, Mintz reported success. She had derived an EC cell line which 
retained a normal female karyotype. Three to five cells only were injected into 
blastocysts in a study of this EC cell line's ability to differentiate normally 
in the embryonic environment (Stewart and Mintz,1981). Only 13% of the 
offspring from these experiments were obvious chimeras by coat colour. The 
mouse showing the highest EC contribution to the coat (judged at 85%) was used 
for extensive GPI analysis. All tissues tested showed extensive contribution by 
the EC cells, ranging from an estimated 10% in the pancreas to 65% in the brain, 
and averaging 43%. Nine chimeric females were selected for a test breeding 
program. The appearance of an agouti coat colour in any of their offspring 
would indicate that an EC cell had differentiated into a functional oocyte. Out 
of 329 offspring, three agouti babies were found, all offspring of one chimeric 
mother, with 65% agouti in her coat. Two of these were females, who 
subsequently also produced agouti offspring in the F2 when mated with the male 
agouti from the Fl. In this study, only one tumor bearing animal was found. It 
was assumed that one of the cells injected into the blastocyst had escaped 
regulation and had continued malignant proliferation. Because completely normal 
embryogenesis, including colonization of the germ line in some cases, was 
apparently the route taken by a large number of the injected cells, the cell 
line was designated METT-l, for "Mouse Euploid Totipotent Teratocarcinoma" 
cells. The "1" was appended optimistically, signifying the first of perhaps a 
number of such EC cell lines that might perform equally well once more euploid 
lines were available. 
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The P10 EC cell line: 
The P10 EC cell line was derived by McBurney and Strutt (1980). Tumors 
were induced by grafting 6.5 day C3H strain embryos to the testes of C3H hosts 
and one EC cell line isolated was found to have a normal female karyotype. This 
line was designated P10. 
The in vivo developmental potential of the P10 line following blastocyst 
injection has been assessed by Rossant (Rossant and McBurney, 1983; and Rossant, 
unpublished observations). In these experiments, 57% of live born offspring 
were obvious chimeras by coat colour (plate 1). These animals were all healthy 
and normal, with no sign of tumor development. GPI analysis of several chimeras 
indicated widespread P10 contribution throughout the tissues of these mice 
although the highest average overall tissue contribution was only 42%. Eleven 
female chimeras were selected for a breeding program, but no colonization of the 
germ line was noted in over 300 offspring. This represents a fairly restricted 
breeding program. Recall that Mintz found only three METT-1 derived progeny 
among about the same number of offspring, and they were all progeny of one 
chimeric mother. Therefore, these negative results do not necessarily exclude a 
P10 contribution to the germ line. 
The recovery rate of live born offspring was rather low in these 
experiments, at 58%. This suggested that some P10 chimeras were not surviving 
to term. Accordingly, several pregnancies were examined pre-term, and abnormal 
fetuses were found. The abnormalities frequently included an open neural tube, 
and an unfused allantois was noted in one fetus as well as complete 
disorganisation in another. The average P10 contribution to these embryos was 
much higher that that seen in the live born offspring and the highest P10 
contributions were almost invariably associated with the most obvious 
developmental abnormalities. When the outcome of full term pregnancies alone is 
Plate 1 P10 Blastocyst Injection Chimeras 
Chimeric mice, produced by injecting 15 to 20 P10 cells 
into the blastocoelic cavity of a Day 3 embryo. 
The pigmentation in the eyes and coat is a visual 
indicator of P10 contribution. GPI marker enzyme 
analysis indicated that live born chimeras such as these 
demonstrated widespread colonization of tissues by 
the P10 cells, but overall P10 contribution did not exceed 50%. 
While these mice remained healthy and tumor free, abnormal 
embryos, with a higher proportion of P10 cells, were observed 
in pregnancies examined pre-term. 
Photo courtesy J. Rossant 
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considered, P10 appears to be a candidate to join METT-1 as another example of a 
karyotypically normal EC cell line which can participate extensively in normal 
embryogenesis following blastocyst injection (Rossant and McBurney, 1983). P10 
has been the most successful EC cell line tested so far in its ability to 
produce normal live born chimeras (Papaioannou and Rossant, 1983). However, 
upon consideration of the loss of abnormal fetuses during gestation, it seems 
reasonable to suspect that high levels of P10 contribution might be incompatible 
with normal development. That is, when the P10 cells constituted a majority 
population, their proliferation and differentiation may not have been completely 
regulated. In order for normal development of P10-embryo chimeras to proceed, a 
majority population of normal embryonic cells may be required to provide the 
proper developmental framework. 
This P10 study differs from the study assessing the in vivo developmental 
potential of METT-1 in that pre-term pregnancies were examined. The development 
of METT-1 embryo chimeras was not assessed during gestation and the rate of live 
births seems rather low, at 31%. It is possible that abnormal METT-1 chimeras 
might have been lost during development as well. The recovery of abnormal P10 
chimeric fetuses indicates that being euploid is not a guarantee of successful 
developmental performance, and suggests that even euploid EC cells are not the 
complete equivalent of normal embryonic cells. This conclusion is given further 
support when the experiments involving injections of P19, MCBurney's other 
euploid EC cell line, are considered. 
The P19 EC cell line 
The P19 EC cell line was derived by McBurney and Rogers (1982). Again, 
tumors were induced by grafting C3H egg cylinder stage embryos to the testes of 
host animals and the P19 cell line was established directly from the primary 
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tumor. McBurney attempts to isolate cell lines as rapidly as possible from 
newly induced teratocarcinomas and this may be the reason for his success in 
establishing EC cell lines which have not undergone karyotypic modification. 
The ~ vivo developmental potential of a clonal subline of P19 (P19S18) 
has been assessed by Rossant (Rossant and McBurney, 1982). When 15 to 20 
P19S18 cells were injected into blastocysts the rate of chimera production was 
high but abnormalities were evident in 9.5 day embryos. The chimeras 
assessed as developing normally were almost always those with lower P19 
contributions than that seen in the abnormal chimeras. 
At 12.5 days gestation, a large number of resorption sites were found, 
indicating high embryo loss. The live chimeric embryos contained relatively low 
P19 contributions, usually less than 50% in the tissues analysed. Only four 
live born chimeras were recovered, and all had obvious tumors on the head along 
with low level P19 contributions to at least some normal tissues. Therefore, 
incomplete regulation of presumably homogeneous cloned P19S18 cells had 
occurred. 
Following publication of her work, Papaioannou (Papaioannou, et gl., 1978) 
was criticized for the large numbers of EC cells injected. From 20 to 40 EC 
cells were injected into blastocysts in those experiments, probably in an 
attempt to facilitate recovery of chimeras with significant EC contributions. 
Illmensee, Martin, Mintz, and Pierce have all expressed the view that the tumors 
present in the chimeric mice recovered in these experiments probably reflected 
incomplete regulation of such a large number of EC cells imposed upon the 
blastocyst. If fewer cells had been injected, these workers all predicted 
complete regulation (Martin, 1980; Pierce, ~ al.,1979; Illmensee and Stevens, 
1979; Dewey, ~ £Ll., 1977). Because P19 cells produced chimeras at such a high 
rate, it seemed feasible to test the outcome of injecting a single EC cell into 
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a blastocyst. When a single P19S18 cell was injected, an improvement in live 
embryo recovery beyond midgestation was noted but only 15% were chimeric and 
most showed the same types of abnormalities in the head region that had been 
seen previously. Only one live born chimera was recovered. This animal had a 
large tumor on the head. So, although P19 is a karyotypically normal EC cell 
line, it appears to be incapable of completely normal embryogenesis (Rossant and 
McBurney, 1982). 
Summary: Comparison of the developmental potential of euploid EC cell 
lines tested to date following blastocyst injection 
A total of six euploid EC cell lines have been tested for normal 
developmental potential following injection into blastocysts. We have 
considered three so far: METT-l, Pl0 and P19. Additionally, Papaioannou and 
her co-workers (1979) derived and tested three others. Only one (C145b) formed 
any chimeras, at a rate less than 1%, and in these the EC contribution was only 
to the yolk sac tissues. Therefore, these euploid EC cell lines, which among 
the various EC cell lines might be expected to most closely resemble normal 
embryonic cells by virtue of their normal karyotype, behave quite differentfy 
from each other, and also quite differently from ICM cells following blastocyst 
injection. In injections of normal ICM cells into blastocysts, 90 to 100 % of 
the offspring are healthy chimeras. Even when a single ICM cell is injected 
into a blastocyst at least 25% of the offspring are chimeric (Papaioannou and 
Rossant, 1983). Some EC cells do not colonize the embryos at all, while Pl0 and 
METT-l have produced normal live born chimeras at a fairly high rate, though not 
at the rate seen following injection of an ICM. Abnormalities of fetal 
development during gestation have been observed following Pl0 injections, and 
one METT-l chimera had a tumor. Abnormal development and tumors have never been 
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seen in chimeras developing from blastocysts injected with ICMs. P19 also gave 
rise to chimeras at a very high rate following blastocyst injection but the 
great majority were abnormal and did not survive. Live born chimeras all had 
tumors (Papaioannou and Rossant, 1983). Clearly then, these EC cell lines 
differ in their response to the blastocyst environment. Rossant and McBurney 
(1983) have considered possible explanations for these differences in response. 
They compare P10 and P19 and point out firstly that the normality of the 
chimeras produced by the two lines is apparently not a simple function of the 
degree of EC contribution. Within the chimeras produced by both lines, there 
may be a correlation between the degree of EC contribution and the degree of 
abnormality. However, P10 chimeras with EC contributions as large as those seen 
in abnormal P19 chimeras were apparently developing normally. It has been noted 
that P10 cells differentiate quite readily ~~, whereas P19 cells are less 
likely to do so, and stem cells always persist in the culture. In producing any 
in vitro EC cell line, cells with the property of continued proliferation are 
selected. Stem cells in the early embryo do not proliferate indefinitely; 
rather, they differentiate. P10 cells may not have diverged in culture as far 
from their normal counterparts as have P19 cells, and may have retained a 
greater ability to respond to normal developmental signals within the blastocyst 
environment (Rossant and McBurney, 1983). The observations on EC-embryo 
chimeras presented to this point suggest strongly that EC cells are not 
completely equivalent to normal pluripotent embryonic cells. 
47 
EC-embryo chimeras produced by the aggregation technique 
The potential of the aggregation technique for making EC-embryo chimeras 
will now be considered. In 1980, two reports of successful aggregations between 
cultured EC cells and morulae were published. Stewart (1980) and Fujii and 
Martin (1980) both found that while EC cells will aggregate successfully with 
cleavage stage embryos, with some variation in adhesiveness between the cell 
lines used, differentiated cell types will not form successful aggregates with 
morulae. The EC-morula aggregates developed into morphologically normal 
blastocysts in vitro. 
Having demonstrated the feasibility of aggregating EC cells with 8-cell 
embryos, both groups went on to test the developmental potential of these 
aggregation chimeras in vivo. Stewart (1982) tested two cell lines, PSA/NG2 and 
PSA/TG12. Both lines are XO and trisomic for chromosome 6. Three to five EC 
cells were aggregated with two 8-cell embryos and very few of the embryos 
recovered during gestation or the live born animals were chimeric. In chimeras, 
EC contribution was found in the embryo proper and in the yolk sac mesoderm, and 
only occasionally to the yolk sac endoderm. The extent of this contribution is 
not given. No mention of abnormalities amongst the chimeric fetuses is made. 
When NG2 cells were aggregated with only a single 8-cell embryo a striking 
difference in the outcome was noted in that most chimeric fetuses were "severely 
malformed" at 12 to 13 days. Further details are not given. 
In his discussion, Stewart points out that aggregation is a simple 
alternative to the blastocyst injection technique for producing viable EC-embryo 
chimeras. The rate of chimera recovery was quite low however. He comments on 
the preferential colonization of the yolk sac mesoderm and suggests that the EC 
cells did not respond to the signals to differentiate endoderm. He does not 
comment on the recovery of abnormal fetuses, but his data suggest that when the 
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number of normal embryonic cells in the aggregates was decreased, the EC cells 
colonized the embryos more readily. Unfortunately, he does not give any 
indication of relative contributions, so we cannot determine if the abnormal 
embryos had higher EC contributions than the normal chimeras. It must be kept 
in mind that the EC cells were aneuploid, with a known lethal trisomy, when 
assessing the significance of the abnormalities. The presence of this trisomy 
in some of the cells of the developing chimeras may have adversely affected 
their development. 
Fujii and Martin published a more detailed assessment of the developmental 
potential of EC-embryo aggregation chimeras in 1983. They anticipated that the 
aggregation technique might increase EC contributions in the chimeras because 
the EC cells are brought into association with the normal embryonic cells 24 
hours earlier than in blastocyst injection. 
They aggregated about 10 to 20 PSA-l or PSA/NG2 cells with a single 8-cell 
embryo. At 10.5 days gestation, they observed a large number of abnormal 
fetuses, reinforcing Stewart's observations of abnormal NG2-embryo chimeras. 
The NG2 cells had colonized the embryos at a high rate: 79% were chimeric, but 
only one of these chimeras appeared to be developing normally. The abnormal 
embryos were classed as retarded and primitive structures only barely 
recognizable as fetuses. These abnormal embryos were heavily chimeric, usually 
with an EC contribution greater than 50%. 
The effect of decreasing the EC component of the original aggregate was 
tested by aggregating the EC cells with two 8-cell embryos. The frequency of 
chimerism was decreased somewhat to 62% and abnormal chimeras were not nearly 
as abnormal as the previous set. No further improvement was noted when three 
embryos were included in the aggregates. These more normal chimeras had lower EC 
contributions than the previous set, generally less than 50%. 
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The rate of live born chimera recovery was low and the EC contribution in 
these animals was sporadic and limited, and one had a tumor. Thus, it appeared 
that aggregation was a very useful technique for producing chimeras at a high 
rate, with high EC contributions in each embryo, but most of these chimeras were 
being lost during gestation due to developmental abnormalities. 
It seemed likely that the high EC contributions were incompatible with 
normal development. However, both PSA-l and PSA1/NG2 are XO and trisomic for 
chromosome 6. The effect of the trisomy on development was of particular 
concern, and further aggregations were performed therefore, between nearly 
euploid EC cells and an 8-cell embryo. When LTl-2D cells (with an elongation of 
1 chromosome #8 as the only known karyotypic abnormality) were aggregated with 
an 8-cell embryo, abnormal chimeras were again recovered. Fujii and Martin 
claim that their more normal karyotype has not given them an advantage, but 
their data chart suggests to me that the abnormal LTl-2D chimeras did not 
exhibit as severe a degree of abnormality as PSA-l abnormal fetuses, despite 
high EC contributions in some cases. 
Fujii and Martin conclude that aggregation is a simple and efficient 
alternative to blastocyst injection for making chimeras. They point out that in 
order to fully explore the developmental potential of an EC cell line, chimeras 
in which the EC cells predominate must be constructed. Their aggregation 
chimeras show high EC contributions, and their data suggest that high EC 
contribution correlates with abnormal development. It would seem then that 
these results support Rossant's hypothesis that normal embryonic cells must 
predominate in a chimera to program normal development, and therefore that EC 
cells do not have the same developmental potential as normal embryonic cells. 
However, certain qualifiers must be attached to this statement. Firstly, Fujii 
and Martin considered the possibility that mixing cells of different 
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developmental stages in an aggregate might adversely affect development. We 
have already seen evidence that EC cells are different from the cells of the 
8-cell embryo. For example, as Martin determined, their protein synthesis 
pattern is quite different from that seen consistently in various cleavage 
stages, and correlates instead with the pattern seen in rCMs from later 
blastocysts. EC cells probably correspond most closely to the embryonic 
ectoderm cells of such rCMs. Fujii and Martin have some evidence for an adverse 
effect on development following aggregation of an rCM or embryonic ectoderm 
cells with an 8-cell embryo. (This conclusion was not completely clear cut from 
their data, however.) While the abnormalities seen in the EC aggregation 
chimeras were of greater magnitude and probably cannot be attributed solely to 
the mismatching of embryonic cell types in the aggregate, the role of this 
mismatching in promoting abnormal development is not entirely clear. 
Secondly, chromosomal aberrations were present in all three cell lines 
tested in the study and may have contributed to the developmental difficulties 
experienced by the chimeras. The presence of a trisomy in two of the lines is 
probably the most serious deviation from the normal karyotype, and the other 
line was nearly euploid. Abnormalities were seen in all three types of 
chimeras, but the most normal EC cell line may have shown an improved 
developmental performance. 
Thirdly, and perhaps most importantly, it is not clear from these 
aggregation studies if the high rate of abnormality is a consequence of the 
aggregation technique ~ se, or if abnormal, highly chimeric embryos can also 
be recovered following injection of these EC cells into blastocysts. A detailed 
study, including examination of preterm pregnancies, of the developmental 
potential of these EC cell lines following blastocyst injection has not been 
undertaken. 
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Questions remain then, concerning the potential of EC cells and lCM 
cells to participate in normal development following aggregation with 8-cell 
embryos. 
At this point, a summary of certain properties of selected EC cell lines 
pertinent to this study might be useful. Table 1 illustrates the following 
relevant points: 
1. Euploid EC cell lines vary in their ability to colonize the embryo 
following blastocyst injection. One EC cell line did not colonize the 
embryo at all and P10 was the most successful in terms of % live born 
animals which were chimeric. 
2. Survival to term is low following injection of EC cells compared to 
injection of lCM cells. Again, Pl0 was the most successful line in 
terms of survival, and none of these Pl0 chimeras had tumors. 
3. During midgestation, many abnormal EC-embryo chimeras were found. 
P10 produced the lowest rate of abnormal fetuses. 
4. Aggregation produces high rates of chimeric offspring but also may 
produce high rates of abnormal offspring, perhaps due to the high EC 
contributions achieved. However, fully euploid EC cells have not yet 
been aggregated with 8-cell embryos, and available data on aggregation 
of lCMs with 8-cell embryos are insufficient to determine whether 
developmental difficulties might be partly due to mismatching of 
asynchronous cell types in the aggregates. Furthermore, it is very 
clear from the table that the only EC cell lines which have been tested 
for their developmental potential following aggregation have not been 
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fully tested for their developmental potential in a chimera following 
blastocyst injection. The limited injection data available for 
PSA-l/NG2 suggests that the rate of live born chimera production is 
very low following injection also, and that highly chimeric, abnormal 
embryos might also be produced and lost during gestation following 
injection. 
Cell line 
or .1YJ2.e 
ICMs 
C145b 
METT-l 
Pl0 
P19S18 
PSA-l/NG2 
PSA-l 
LTl-2D 
TABLE 1 
Karyotype 
Euploid 
Euploid 
Euploid 
Euploid 
Euploid 
XO,ts 6 
XO, ts 6 
1 #8 elon-
gated 
The in vivo developmental performance of selected EC cell lines in 
EC-embryo chimeras 
Method used to 
make chITIi8ras 
Bst. injection 
Bst. injection 
Bst. injection 
Bst. injection 
. Bst. injection 
Bst. injection 
Aggregation 
Aggregation 
Aggregation 
DEVELOPMENTAL PERFORMANCE 
Midgestation 
~ chimeric ~ chimeras 
abnormal 
N.A. N.A. 
(most survive to term) 
<1% (y.s.) 
only 
N.D. 
100% 
69% 
N.D. 
79% 
58% 
40% 
N.D. 
40% 
55% 
N.D. 
93% 
58% 
83% 
Survival 
to term 
---
80% 
31% 
58% 
36% 
'? 
13% 
N.D. 
N.D. 
Term 
~ survivors 
chimeric 
90 to 100% 
0% 
13% 
57% 
27% 
23% 
29% 
N.D. 
N.D. 
Tumors 
No 
Y~s (1) 
No 
Yes 
No 
Yes 
N.D. 
N.D. 
N.A.: not applicable N.D.: not determined ts: trisomy y.s.: yolk sac 
\..J\ 
\..,J 
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THE QUESTIONS RAISED IN THIS STUDY 
The phenomenon of regulation and participation in normal 
development by cultured EC cells upon their return to the 
embryonic envirnonment is of particular interest in this study. 
The Pl0 and P19 cell lines seemed to be ideal candidates 
as EC cell lines which could be used to explore more completely 
the effects of aggregating EC cells with morulae. They are 
euploid and their response to the embryonic environment 
following blastocyst injection has been fully explored. 
It was hoped that by aggregating these cells with early morulae 
chimeras might be generated at an even higher frequency and that 
the EC cells would predominate in at least some of the chimeras 
such that the in vivo developmental potential of euploid EC 
cells could be more completely assessed. 
The following questions are considered in this study. 
1. Aggregation is an efficient technique for producing 
EC-embryo chimeras, but apparently produces a high 
level of abnormality. Is there really a difference in 
the rate of abnormal development produced by aggregation 
compared to blastocyst injection? 
2. If so, does a high rate of abnormality correlate with 
higher EC contributions achieved in aggregation chimeras~ 
J. Alternatively, are there developmental problems 
associated with mismatching of cells from different 
developmental stages? If so, ICM-morula aggregates 
would also be expected to show abnormalities of 
development. 
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4. Can an improvement in the developmental performance 
of an EC cell line be induced by a pretreatment of 
EC cells with retinoic acid? If so, P19 cells, 
which seem to persist to some degree as stem cells 
in all chimeras, might be committed to differentiation 
and more normal development as a result of retinoic 
acid pretreatment. 
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MATERIALS AND METHODS 
Mice and staging of embryos 
Embryos were obtained from originally random bred CD-l mice (Charles River, 
Quebec). For most experiments, it was necessary that embryos were homozygous 
for one or the other GPI (glucose phosphate isomerase) type. The random bred 
mice were typed by testing tail blood samples according to the GPI analysis 
method detailed in a subsequent section. Breeding stocks homozygous for the 
Gpi-la allele and similar stocks homozygous for the Gpi-lb allele were 
established and maintained at Brock University. 
Females in estrus were caged individually with males in the late afternoon. 
The mice were maintained on a 14 hour light, 10 hour dark cycle and mating was 
assumed to occur at the midpoint of the dark cycle, that is, around 12 a.m. 
Mating was detected by the presence of a vaginal plug, and the morning on which 
the plug was found was considered to be Day 0 of the pregnancy. The afternoon 
of the first day post coitum is therefore Day 0.5 of pregnancy. 
Eight-cell embryos were obtained by flushing the oviducts in the late 
morning or early afternoon of Day 2 while blastocysts were obtained by flushing 
the uteri in the late morning or early afternoon of Day 3. 
Maintenance of cell lines 
The two EC cell lines used in this study were Pl0 and P19, and were a gift 
from M.W. McBurney. These EC cell lines were derived by him from the tumors 
induced following grafting of 7.5 day C3H embryos to the adult kidney or testis. 
Pl0 is a female, diploid, karyotypically normal cell line (McBurney and Strutt, 
1980) while P19 is a male, diploid, karyotypically normal cell line (McBurney 
and Rogers, 1982). Both cell lines are homozygous for the Gpi-lb allele. 
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Frozen cell stocks of the cultures used in this study were suspended in 
fetal calf serum containing 10% DMSO and stored at _70°C. The Pl0 cells used 
were grown up from frozen stocks of originally diploid cells (karyotyped by M.W. 
McBurney). Pl0 is a feeder dependent cell line. STO cells (a mouse fibroblast 
cell line derived by A. Bernstein, and described by Martin and Evans, 1975) were 
used to establish a feeder layer. The STO cells were maintained in-< -modified 
MEM (Gibco) containing penicillin and streptomycin, and supplemented 
with 5% newborn and 5% fetal calf serum (Flow Laboratories). Preparation of this 
medium is described in Appendix 1. The STO cells were subcultured every two or 
three days. When feeders were required, mitomycin C (Sigma) was added to 
confluent cultures to a final concentration of 0.01 mg/ml. The drug treatment 
was continued for 1.5 hr, then the cells were washed twice with PBS (Appendix 1) 
and harvested. The resuspended pellet from a confluent culture in a 60mm dish 
was used to establish feeder layers in three similar Falcon tissue culture grade 
petri dishes. Each dish was inoculated with about 1 x 10 0 feeder cells. 
Mitomycin C is an inhibitor of DNA synthesis which causes cross-linking of the 
DNA proportionally to the GC content (Harbers et al., 1968). 
Dishes of feeders (freshly prepared, or not more than 2 days old) were 
inoculated with about 3 x 10 5 Pl0 cells. The EC cells grew slowly as colonies 
on top of the feeder monolayer, and were fed with fresh medium after 2 days and 
subcultured at a 1:4 dilution after 3 or 4 days. Pl0 cells will differentiate 
quite readily and continued proliferation of stem cells seems to be favored by 
this fairly frequent subculturing and vigorous trypsinization. The trypsin 
solution contained 0.125% trypsin (Sigma) in Ca~+, Mg++- free PBS containing 
0.2mM EDTA, and the colonies were dissociated in this solution by incubating at 
o 
37 C for about 5 minutes. After a few weeks in culture, the growth rate of the 
cells quite often increased. This increase in the growth rate may reflect the 
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loss of an X-chromosome (G. Paterno and M. McBurney, unpublished observations). 
While freshly thawed cultures were substituted quite frequently, it is possible 
that not all aggregations were made with XX cells. 
The P19 cells used were from the P19S18 subclone. P19 cells 
are feeder independent, and were grown in~medium with very frequent 
subculturing, at fairly high cell densities. The cells were subcultured every 2 
days, and sometimes daily, at dilutions no greater than 1:4 of a confluent 
culture (about 2.5 x lOS cells per dish) to maintain an exponentially growing 
culture of EC cells. Longer intervals led to extensive death of the stem cells 
and greater dilutions allowed emergence of a significant differentiated 
population. 
P19S1801Al is a mutant clone of P19S18 selected for 6-thioguanine and 
oubain resistance (McBurney ~ ai., 1982). It is a naturally occurring variant 
of P19S18 which will not incorporate~H}hypoxanthine into DNA due to the lack of 
the enzyme hypoxanthine-guanine phosphoribosyl transferase. 6-thioguanine 
competes with guanine for HGPRT. As thio-GMP it is incorporated into nucleic 
acids as a poisonous analog (Harbers g! ~., 1968). This pathway is 
shown in Figure 6. These cells were also a gift from M. McBurney, and they 
behaved in culture like the P19S18 parental line. 
All cell cultures were grown at 37°C in a humid incubator containing 5% C02 
in air. 
Preparation of EC-morula aggregates 
Eight-cell embryos were flushed from the oviducts of 2.5 day pregnant mice 
in PBl medium (Whittingham and Wales, 1969, Appendix 1). These embryos were 
mostly homozygous Gpi-la/Gpi-la except those used for in vitro experiments which 
were untyped. Mouth controlled finely drawn Pasteur pipets were used for all 
Figure 6 Interconversions of purine derivatives 
The enzyme hypoxanthine-guanine phosphoribosyl transferase (HGPRT or HPRT) is active 
in tissues in a salvage pathway, permitting reutilization of purines or purine 
derivatives from nucleic acid breakdown. 
Free purines 
Hypoxanthine 
or Guanine 
+ phosphoribosyl 
pyrophosphate ~ 
HGPRT 
..... 5' nucleotide + 
Inosinic acid 
or Guanylic acid 
Inosinic acid is the precursor for both AMP and GMP. 
Summary of interconversions of purine derivatives 
"''''"2-
PPi 
~\h. 
~,,~~ 
I II CH '-~Y\11 . l ~ I I1l~I'1~':: rAderiC acid ~ AinOSine > Adeiine r "~AI "'" H 
sinic acid > Inosine .." Hypoxal 
b--p 1 t HPlT " 11 ~('l 
[
xanthYliC acid :> Xanthosine >Xanthine 7'1-\ 
it i i if' r~\ '"'~~ . I. ...v I I 0-\ 
1 II'~ Guanylic acid ~ guanoslne" ~ guanlne ~~.)'-- ./ kl.~~NArf 4 l' HGPRT ~ I 'N ~ 
k.'oos«.-p Thio- + Thioguanine 
GlVlP ( .. 1 
The 5' ribonucleotides can be converted to purine deoxyribonucleotides and incorporated 
into DNA. (from White e~ al., 1968) 
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60 
flushing and embryo manipulations. The zonae pellucidae were removed by 
incubating the embryos for a few seconds in acid Tyrode's solution (Appendix 1) 
before transferring back to PBl medium. 
Aggregations were carried out in microdrops of~ medium under oil. The 
embryos were washed in olmedium then transferred singly to the microdrops. 
The day prior to aggregations, a subconfluent EC culture was harvested and 
diluted about 1:4 into a bacteriological grade dish. EC cells adhere poorly to 
this surface, and remain in suspension. On the day of the experiment, EC 
clumps which resembled ICMs in size and morphology were selected for aggregation 
with the morulae. Feeder cells are larger than Pl0 cells and tend to attach 
even to this surface, and differentiated Pl0 cells tend to form very loose 
associations of rounded cells which were readily distinguishable from the EC 
clumps selected. 
The EC-morula aggregates were made by gently blowing the EC cell clumps 
into contact with the embryos in the microdrops. The aggregates were incubated 
o 
for about 30 minutes at 37 C in 5% C02 in air then checked for adherence. 
Usually aggregation was beginning, but adjustments were made where necessary 
(Plate 2). o The aggregates were then incubated overnight at 37 C in the C02 
incubator. 
Isolation of inner cell masses by immunosurgery and preparation of ICM-morula 
aggregates 
Homozygous Gpi-lb/Gpi-lb blastocysts were flushed from the uteri of 3.5 day 
pregnant mice in PBl medium. Occasionally a few late morulae were recovered, 
but the embryos were usually at the early blastocyst stage. Zonae were removed 
with acid Tyrode's solution and ICMs were isolated by immunosurgery. 
Immunosurgery is a technique developed by D. Solter (Solter and Knowles, 1975) 
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which relies on the susceptibility of mouse blastocysts to complement-dependent 
antibody cytotoxicity. In the first step of the 2-step procedure, the 
o blastocysts were incubated for 45 min at 37 C in a 1:8 dilution (in PB1) of a 
rabbit antiserum raised against mouse 12 day embryonic tissue by A. Croy. 
Unbound antibody was removed by rinsing the embryos twice in drops of PB1, then 
they were incubated in rabbit complement (Low-Tox M Rabbit Complement, Cedar lane 
o 
Laboratories) diluted 1:10 in serum-free PB1, for 35 min at 37 C. During this 
incubation, complement mediated lysis of the trophoblast cells occurs, and cell 
debris can be removed by gentle pipetting. The ICMs were washed twice in PBl 
and allowed to recover for at least 15 minutes in PBl prior to aggregation. 
Homozygous Gpi-la/Gpi-la morulae for aggregation with ICMs were collected 
in the same manner as for EC-morula aggregates, and transferred to~ microdrops. 
The ICMs were rinsed in oZ medium then blown into contact with the morulae (Plate 
2). Following adherence, these aggregates were also incubated overnight at 37 cC 
in 5% C02 in air. 
Transfer of aggregates and control embryos to recipients 
The following day, successful aggregates and controls were transferred to 
recipient foster mothers (homozygous Gpi-la/Gpi-la) which were 2.5 days 
pseudopregnant. Pseudopregnancy was established by mating females in estrus 
with vasectomized males. The physical stimulation of copulation induces the 
development of functional corpora lutea in the ovaries following ovulation, such 
that the uterus is prepared for implantation of embryos (Whitten and Champlin, 
1978). Because the recipient is only 2.5 days pseudopregnant while 3.5 day 
embryos are transferred, some delay in development due to the experimental 
manipulations can be accommodated. From the time of transfer, gestational age 
was calculated from the recipient; that is, the day of transfer was counted as 
Plate 2 The formation of aggregates between Pi0 clumps 
or ICMs and morulae 
A Aggregation of three ICM-sized clumps of Pi0 cells with 
a 2.5 day morula (M). Two of the Pi0 clumps have failed 
to adhere to the morula initially. 
B The same aggregate, 40 min later, after adjustment. 
C Aggregation of three ICMs with a morula (M). The aggregate 
was photographed 45 min after construction. 
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Day 2.5 of pregnancy. 
The mouse uterus is bicornuate, and five to six aggregates were transferred 
to one uterine horn of each recipient while controls were t r ansferred to the 
contralateral horn. The controls were embryos which had been flushed on the 
previous day and treated in the same way as the morulae used in the aggregates. 
The embryos were surgically transferred to the recipients (anaesthetized 
with Avertin, Appendix 1) through a dorsal incision in the body wall. The 
transfer pipet was a finely drawn Pasteur pipet filled partly with light 
paraffin oil. The embryos were drawn into the capillary stem in PBl medium and 
delivered through a needle hole into the uterus in a minimal volume of PB1. 
Blastocyst injections 
Blastocyst injections were performed by Janet Rossant, using the technique 
described by Gardner (1968, 1978). The injections were made with a Leitz 
micromanipulator assembly, with the blastocysts in hanging drops of medium in 
manipulation chambers filled with heavy paraffin oil. The blastocysts were held 
on a holding pipet by suction at the embryonic pole and a triangular hole was 
made in the trophectoderm opposite the ICM with three glass needles. EC cells 
were injected through this hole into the blastocoelic cavity of homozygous 
Gpi-la/Gpi-la 3.5 day blastocysts via an injection pipet. Injected blastocysts 
were allowed to recover for about 1 hour before transfer to the recipient uteri. 
Recovery of embryos at 9.5 to 11.5 days development from recipients 
Taking the day of transfer as Day 2.5 of pregnancy, the transferred embryos 
were allowed to develop in utero for 7 to 9 days after transfer, and recovered 
between Day 9.5 and Day 11.5 of pregnancy. After careful assessment and 
comparison of the developmental stage achieved in both control and experimental 
embryos, the experimental embryos were dissected into three component tissues, 
and the tissues were prepared for GPI analysis. Each conceptus was dissected 
into ectoplacental cone (EPC), yolk sac (extraembryonic membrane), and embryonic 
fractions. Each tissue sample was transferred to a clean petri dish in PBS, 
washed in PBS, and a drop of distilled water was added to each sample. The 
o 
samples were then frozen at -20 C. 
GPI analysis 
Glucose phosphate isomerase (GPI) was used as the marker enzyme to monitor 
the contribution of the added EC cells or ICM cells to the developing chimeras. 
The method used for GPI analysis of the embryonic t l ssue samples recovered was 
the micro starch gel technique developed by A. Peterson (Peterson ~ ~., 
1978). This method is designed to detect GPI isozymes in nanogram tissue 
samples, and is sensitive enough to detect a 5% contribution by each isozyme in 
chimeric samples. 
The gels were 12% electrostarch (Electrostarch Co., Wisconsin) in 3.75 mM 
Tris, 1.3 mM citrate buffer, pH 7.2. After heating the starch mixture in a 
stoppered side-arm flask over a flame until it cleared and thickened, the 
mixture was degassed by connection to an aspirator, and distributed amongst gel 
molds. The gels were allowed to set in the molds at room temperature for 2 
hours, forming gels 8 cm x 10 cm x 2mm thick. The samples were adsorbed onto 
small pieces of cellulose polyacetate electrophoresis strips (Sepraphore III, 
Gelman) dipped in tissue (or blood) lysates. After blotting, the samples were 
inserted into small grooves cut in the gel with a gel comb, the gels were 
positioned across bridge tanks, wicks were applied, and the gels were covered 
with plastic film. Electrophoresis was at 250 volts for 1.5 hr at 4°C. The 
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running buffer was 0.13 M Tris, 0.047 M citrate, pH 7.2 and migration of the GPI 
isozymes was towards the cathode. Following separation of the isozymes, they 
were visualized by staining. 
Nitrocellulose filters (Sartorius, 47mm diameter, 0.45~m pore size) were 
applied over the gels and the samples were allowed to absorb onto the filters 
for about 10 minutes. A staining well was created by greasing a rubber O-ring 
of slightly smaller diameter than the filter and pressing it firmly into place 
on the filter. The staining mixture for 4 filters contained the following: 
7.6 ml Tris-citrate running buffer (0.13m Tris, 0.047M citrate, pH 7.2) 
0.2 ml D-fructose-6-phosphate (Sigma, diNa salt, Grade 1, 75 mg/ml) 
15~1 glucose-6-phosphate dehydrogenase (Sigma, Type XV from Baker's 
yeast, 50 units/ml) 
0.2 ml NADP (Sigma, Na salt, 10 mg/ml) 
0.2 ml PMS (phenazine methosulfate, Sigma, 1.8 mg/ml) 
0.2 ml NBT (nitro blue tetrazolium, Sigma, Grade III, 10 mg/ml) 
1.3 ml MgC12 (0.25M MgC12) 
o Staining was carried out at 37 C in the dark for about 30 minutes. In the 
staining reaction, the formation of glucose-6-phosphate, catalyzed by the 
isomerase utilizing fructose-6-phosphate as the substrate, is followed by 
dehydrogenation catalyzed by glucose-6-phosphate dehydrogenase, and reduction of 
NADP. This reduction is coupled to the reduction of the tetrazolium dye, 
producing formazan which precipitates onto the filters as a blue spot wherever 
glucose phosphate isomerase is present. These reactions are shown in Figure 7. 
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Figure 7 The reactions in the staining procedure 
for glucose phosphate isomerase. 
1. GPI 
Glucose-6-phosphate Fructose-6-phosphate 
2. Glucose-6-phosphate + NADP :;; ....... :::== ........ :! 6-phosphogluconic 
acid + NADPH2 G-6-p 
dehydrogenase 
3. NADPH2 + X ----~> NADP + XH2 (X = reducible dye) 
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The morulae used in aggregations were homozygous Gpi-1a/Gpi-1a as were the 
recipients. The EC cells and the ICMs were homozygous Gpi-1b/Gpi-1b. Therefore, 
the appearance of the BB isozyme band in the embryonic tissue samples analysed 
was the indicator of chimerism. The stained filters were permanently preserved 
by submersion in H20-ethanol-acetic acid (5:5:1) fixative overnight. After 
rinsing, the relative quantities of AA and BB isozymes in each chimeric sample 
were estimated visually from the densities of the blue spots. 
Recovery of embryos on Day 5.5 or Day 6.5: Tissue fixing, processing and 
embedding for histology 
In some experiments, development of embryos was assessed at an earlier 
stage, at the time of egg cylinder formation in normal development. At this 
time the embryo is very small and is embedded within a large maternal decidual 
swelling, and is best examined in histological preparations. Recipients were 
killed 3 or 4 days after the transfers, on Day 5.5 or Day 6.5, and the uteri 
were pinned onto foil supports for fixing overnight in AFA fixative 
(H20:ethanol:40% formalin:acetic acid, 5:3:1:1). The following day, the AFA was 
poured off, 50% ethanol was added for 1 hour, followed by 70% ethanol for at 
least 1 hour, and the tissue was then ready for further processing in a 
Tissuematron automatic processor. 
Each control or aggregate implantation site, easily recognizable as a 
prominent swelling, was dissected from the uterus and these samples were 
processed in the Tissuematron. In the automatic processing, they were first 
dehydrated through a series of alcohols, then cleared in xylene, and finally 
infiltrated with paraffin wax (TissuePrep, Fisher Scientific). This series is 
described in Appendix 1. Each implantation site was embedded in a wax block and 
serial 7pm sections were cut sagittal to the embryo on a rotary microtome. The 
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sections were mounted on slides with Mayer's albumin then stained with 
hematoxylin and eosin (Appendix 1) and cover-slipped with Canada balsam. 
In ~ culture of embryos 
In some experiments, the embryos were not transferred to recipients 
following the overnight culture period, but were allowed to continue their 
development in vitro in the microdrop cultures. The following day (48 hours 
after flushing the morulae) the embryos were transferred to a tissue culture 
grade surface in order to facilitate attachment and blastocyst outgrowth. These 
outgrowths were sometimes cultured in~ microdrops in tissue culture petri 
dishes, but were more conveniently established in tissue culture chambered 
slides (8 chambers, Lab-Tek) with about 300~1 of medium in each chamber. After 
4 or 5 days in the chambered slides, the outgrowths were fixed and stained. 
After pouring off the medium, each outgrowth was washed with PBS, fixed for 
about 10 minutes in ethanol-acetic acid (3:1), washed with ethanol, and allowed 
to air dry prior to staining with Giemsa (Appendix 1). 
Labelling of outgrowths and autoradiography 
In some experiments, a positive identification of the embryo derived cells 
in outgrowths from EC-morula aggregates was desirable. The embryo derived cells 
could be distinguished from EC derived cells if the aggregates were made with 
hypoxanthine phosphoribosyl transferase negative (HPRT-) P19S1801Al (OlAl) 
mutant cells. After the outgrowths were well established in chambered slides 
(usually 6 days to 1 week after the EC-morula aggregates were made) the cells 
were incubated with[3H]hypoxanthine in a pulse labelling. The culture medium 
was withdrawn from each well and 200~ of fresh o(medium, containing 2~Ci 
[3~hypoxanthine (Amersham, 1.2 Ci/mmol) were added to each well. Labelling was 
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o 
continued for 2 hours at 37 C in the C02 incubator, then the medium was 
withdrawn, the outgrowths were washed with PBS, and fixed as before. In 
preparation for autoradiography, the partioning piece and the gasket were 
removed from each chambered slide, leaving a standard microscope slide. The 
slides were coated with Kodak NTB2 Nuclear Track Emulsion in a dipping chamber, 
o 
then left in the dark, dry, at 4 C for 1 week before developing (Kodak D19 
developer, 1.5 min; stop; fixer,S min) and staining with Giemsa. 
Retinoic acid treatment of EC cells 
In some experiments, P19 (P19S18 or P19S1801Al) cells were treated with 
retinoic acid (RA) prior to aggregation with morulae. The retinoic acid (all 
-~ trans, Eastman) was dissolved in DMSO at 10 M and aliquots were stored at 
o 
-70 C. These stocks were freshly prepared every 3 months. When treatment was 
"S to be initiated, an aliquot was serially diluted to 10 M in PBS. In 48 hr RA 
~ treatments, RA was added to a subconfluent monolayer to 10 M for the first 24 
hr period. The cells were then harvested, diluted 1:4 into a bacteriological 
~ dish and fresh retinoic acid was added, again to 10 M. In 24 hr treatments, 
the retinoic acid was added to a freshly inoculated bacteriological dish to a 
-7 final concentration again of 10 M RA. These suspension cultures were incubated 
overnight, and small clumps were selected the next day and used to make 
aggregates with morulae. These aggregates were cultured overnight with no 
further retinoic acid treatment, then transferred to recipients or cultured 
further in vitro. In some cases, treated P19 cells were injected into 
blastocysts. 
Aliquots of RA-treated cell clumps were plated out along with aliquots of 
untreated cells from overnight suspension cultures into tissue culture dishes to 
monitor differentiation of the cells in vitro. Differentiated cell cultures 
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could be fixed and stained with Giemsa. 
Indirect immunofluorescence assays 
In some experiments, a positive identification of undifferentiated EC cells 
amongst the various cells in outgrowths from RA treated lumps was desirable. 
An indirect immunofluorescence assay was employed for this purpose. This assay 
takes advantage of the expression of SSEA-1 antigen by undifferentiated EC 
cells, and the loss of the stage specific embryonic antigen during 
differentiation (Solter and Knowles, 1978). P19S1801A1 clumps, untreated, or 
pretreated with retinoic acid for either 24 or 48 hours, were plated out in 
tissue culture chambered slides. To facilitate adherence and spreading of the 
cells, small clumps, about the size of those aggregated with morulae or injected 
into blastocysts, were selected and about six to ten were added to each well. 
Following a 2 day outgrowth period, the medium was removed from each well, the 
cells were washed twice with PBS, then fixed with cold methanol for 10 minutes 
on ice and air dried. Each outgrowth was then incubated with normal rabbit 
serum, diluted 1:300 in 200~1 of PBS for each well. This preincubation was 
designed to block any non-specific antibody binding in the subsequent reactions. 
Following this 30 min preincubation on ice, the outgrowths were rinsed 2X in PBS 
and incubated with the primary antibody. The primary antibody was monoclonal 
IgM anti-SSEA-1, a gift from D. Soltero The recommended dilution for this 
preparation was 1:200 to 1:300 and after trials with control P19 cultures, a 
dilution of 1:200 in 200~1 PBS per well was used in all assays. After a 30 min 
o 
incubation at 37 C, the outgrowths were washed 3X with PBS, and incubated with 
the secondary antibody. The secondary antibody was an anti-IgM antibody raised 
in a rabbit and FITC conjugated (that is, conjugated with fluorescein 
isothiocyanate). This was supplied as a lyophilized preparation from Bionetics 
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and reconstituted to 2 ml with sterile distilled water. Aliquots were stored at 
o 
-70 C and a dilution of 1:10 in PBS was found to be appropriate after trials on 
control P19 cultures. After a 45 min incubation with the secondary antibody at 
37 Q C, the outgrowths were washed 5X with PBS. The partioning piece and gasket 
were removed from the chambered slides and the outgrowths were mounted in 
glycerol-PBS (9:1) and examined for fluorescence on a Zeiss Universal 
photomicroscope equipped with epi-fluorescence blue (485) and green (546) 
filters. 
Fluorescence was photographed on Kodak Tri-X (ASA 400) film, using a 
constant exposure of 120 sec, at a reciprocity setting of 0 on the Zeiss MC 63 
exposure meter. 
Karyotyping procedures: Chromosome preparations from Pl0 cells 
Chromosome preparations were made from the Pl0 cells using the methods of 
McBurney (1976) as a guide. A well developed Pl0 culture was split 1:2 the day 
previous to provide an exponentially growing culture. Colcemid (Gibco, 
10jUg/ml) was added to each culture to a final concentration of 0.06~g/ml and 
o 
the cultures were incubated at 37 C for 15 min. The medium was withdrawn and 
collected along with a PBS wash to minimize the loss of floating mitotic cells, 
and the remaining cells were harvested by trypsininzing. The total cell pellet 
was resuspended in about 1 ml of medium. Following swelling in hypotonic 
(0.56%) KCl for 10 to 15 min at room temperature, the cells were spun down and 
resuspended in a minimal amount of KC1. The cells were fixed for 30 min on ice 
in methanol:acetic acid (3:1) added dropwise initially to 10 ml. The cells were 
next spun down and resuspended in a small volume (about 1 to 1.5 ml) of cold 
fix. Slides were dipped in ice-cold water, then the cell suspension was dropped 
from a 15 cm height onto a wet slide and the spread was dried quickly over a 
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flame. The spreads were stained with Giemsa in phosphate buffer, pH 6.8 
(Appendix 1) or alternatively, some spreads were G-banded, according to 
the following procedure. The slides were rinsed in 0.15 N NaGl then dipped in 
0.1% trypsin in 0.15N NaGl for 20 to 30 sec. They were then rinsed 2X in 0.15 N 
NaGl, stained for 6 min in Giemsa in phosphate buffer, pH 6.8, rinsed 2X in 
distilled water and dried. 
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RESULTS 
I AGGREGATIONS OF EC CELLS WITH MORULAE 
1. Aggregations of Pl0 cells with morulae 
la. Aggregations of a single Pl0 clump with a morula 
In these experiments single clumps of Pl0 cells which resembled ICMs in 
size and morphology were selected from suspension cultures and aggregated with 
morulae. Clumps of this size contain about 15 to 20 EC cells (Rossant and 
Papaioannou, in press). Transferred embryos and controls were left to develop 
for seven to nine days in the recipients following transfer and were recovered 
on Day 9 to Day 11 of development. Table 2 gives embryo recovery data for 
these experiments. 
The implantation and embryo recovery rates were high for both controls and 
aggregates in these experiments. The aggregate embryos recovered are described 
in Table3. The first six embryos in this table were recovered at 9.5 days 
gestation while the next 16 were recovered at 10.5 or 11.5 days gestation. GPI 
analysis indicated that all 22 embryos were chimeric, and that Pl0 contribution 
to these embryos was very high. Six of these embryos (numbers 9, 12, 13, 15, 18 
and 21) were judged to be totally Pl0 derived and a further ten embryos were 
considered to be at least 75% Pl0 derived. In only one embryo (#4) was the Pl0 
contribution judged to be less than 50%. 
These embryos were almost all judged to be developing abnormally at 
midgestation when compared to controls. The control fetuses were all 
well-formed. The head was always well developed, with visible optic vesicles 
and full closure of the neural tube evident. Body development had reached 
the limb bud stage, and there was an extensive array of somites. 
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Table 2 
Embryo recovery data following transfer of Pl0-morula aggregates and controls 
embryos transferred 
implants (% transferred) 
resorptions (% implants) 
embryos (% implants) 
Control morulae 
24 
19 (79%) 
4 (21%) 
15 (79"10) 
overall embryo recovery: 
Pl0-morula 
aggregates 
41 
29 (71"10) 
7 (24"10) 
22 (76%) 
embryos recovered/embryos transferred: 
controls: 62"10 aggrega tes: 54"10 
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Aggregations of a single Pl 0 clump with a morula 
Embryo and description 
1. small, allantois unfused 
2. small, allantois unfused 
.3 . small 
4. normal 
5. small, allantois unfused 
very small 
very -small-: Ii ttle-body-
Embryo 
proper 
6. 
7. 
8. 
9. 
10. 
misshapen head, little body 
small, little body 
11. 
12. 
1.3. 
14. 
15. 
small, swollen, allantois 
unfused 
disorganised tissue 
small, swollen, a llant ois 
unfused 
misshapen head, little body 
disorganised tissue 
swollen head, little body 
16. small, deformed 
17. small, allantois unfused 
18. small, allantois unfused 
19. swollen head, allantois 
unfused 
20. swollen head, allantois 
unfused 
21. very small 
22. extremely small 
GPI Analysis 
Extraembryonic 
membranes 
-
, -
EPC: ectoplacental cone fraction of the conceptus 
EPC 
The black portion of each diagram represents Pl0 contribution. 
The first 6 embryos were recovered at 9.5 days gestation, 
while the remainder were recovered at 10.5 to 11.5 days gestation. 
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The Pl0 chimeras on the other hand freq~ently were small and retarded in 
their development relative to the controls. Typically, they had a misshapen 
head, sometimes larger on one side than the other, and the neural tube was often 
open. The head often had a swollen appearance. These embryos generally 
exhibited very little body development, and an array of somites was very rarely 
seen. A common defect was an unfused allantois, recognized as a sac or 
bulb-like structure posterior to the embryo. Embryos 11 and 14 consisted of 
disorganized tissue, with the only recognizable structure being a small group 
of somites within an otherwise unformed sac of tissue in Embryo #14. Embryo #4 
was the only embryo judged to be developing normally. This was the embryo rated 
as having the lowest Pl0 contribution, around 40%. 
The Pl0 cells also contributed to the extraembryonic membrane fraction of 
these chimeras, but the Pl0 contribution to this fraction was considerably less 
extensive than to the embryo proper. Contribution was estimated at 50% in five 
samples, and less than 50% in the remainder. 
The Pl0 cells did not contribute to the ectoplacental cone fraction of the 
chimeric conceptuses except for a trace in two samples. 
lb. Aggregations of three Pl0 clumps with a morula 
In this series of Pl0 aggregations, the Pl0 component of each aggregate was 
increased by aggregating three of the ICM-sized clumps of EC cells from 
suspension cultures with each morula. Table 4 shows the embryo recovery data 
for this series. 
78 
Table 4 Embryo recovery data following transfer of triple Pl0-morula aggregates 
and controls 
Control morulae 3Pl0-morula 
aggregates 
embryos transferred 39 31 
implants (% transferred) 35 ( 90"1.) 23 (74"1.) 
resorptions (% implants) 6 ( 1 7"!.) 6 ( 26"1.) 
embryos (% implants) 29 (83"1.) 17 ( 7 4"1.) 
overall embryo recovery: 
embryos recovered/embryos transferred 
controls: 74% 3Pl0-morula aggregates: 55% 
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Again, these aggregate embryos implanted in the uterus at a high rate 
following transfer and the resorption rate in the early post-implantation period 
was low such that embryo recovery was high at midgestation. Table 5 describes 
15 of the 17 aggregate embryos recovered in these experiments (two embryos 
recovered were too small for GPI analysis). Again, GPI analysis revealed that 
all 15 embryos were chimeric. However, P10 contribution to the first ten 
embryos was generally lower than that seen in the previous set. None of these 
embryos was judged to be totally P10 derived, and only four of the ten were 
judged to at least 75% P10 derived. The remaining six embryos had a maximum of 
50% P10 contribution. These first ten embryos were recovered at 9.5 days 
gestation. These embryos were very small and undeveloped compared to the 
controls, and were smaller than the comparable single P10-morula aggregates 
recovered at 9.5 days. The next five embryos were allowed to develop a further 
two days before recovery at 11.5 days gestation. These five embryos had very 
high P10 contributions, and were all judged to be totally, or very nearly 
totally P10 derived. 
The embryos recovered at 9.5 days were so retarded in their development 
that specific abnormalities could not be assessed. By 11.5 days development 
abnormalities were clearly evident. Typically, the head was misshapen, the body 
showed very little form, and the allantois was unfused. Control embryos 
recovered in these experiments were all developing normally. 
Again, P10 contribution to the extraembryonic membranes was lower than to 
the embryo proper, and P10 contribution to this fraction did not increase with 
continued development. Although no membrane fraction had a P10 contribution 
greater than 50%, eight of 13 fractions analysed were judged to be 50% P10 
derived. In the previous set, where P10 contribution to the aggregate was lower 
at the outset, only five of 20 membrane fractions were judged to be at least 50% 
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TABLE 5 
Aggregations of 1 Pl0 clumps with a morula 
Embryo and description 
Embryos recovered at 9 days 
1. small 
2. undeveloped body 
3. small 
4. small 
5. small 
6. small 
7. small 
8. swollen, disorganized 
9. very small 
10. very small 
Embryos recovered at 
11. extremely small, 
formed 
11 days 
badly 
12. larger, misshapen head, 
little body development 
13. misshapen head, unfused 
allantois 
14. misshapen head, little 
body development 
15. misshapen head, unfused 
allantois 
Embryo 
proper 
gestation: 
• 
• 
• 
• 
• 
GPI Analysis 
Extraembryonic 
membranes 
-
(J 
(J 
(J 
~ 
EPC: ectoplacental cone fraction of the conceptus 
The black portion of each diagram represents Pl0 contribution. 
EPC 
0 
0 
0 
(!) 
0 
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derived. 
The P10 cells again did not colonize the ectoplacental cone fraction of 
these conceptuses beyond a trace in two samples. 
lc. Aggregations of a single P10 clump with two morulae 
In this series of P10 aggregations, the P10 component of each aggregate was 
decreased at the outset by aggregating a single P10 clump, containing 15 to 20 
P10 cells, with two early morulae. Therefore, in these aggregates the numbers 
of EC cells and normal embryonic cells were about equal. These aggregates were 
transferred to recipients with the appropriate controls, which in these 
experiments were double morula aggregates. Recovery of these embryos was 
undertaken at 10.5 days development and the embryo recovery data is given in 
Table 6. 
Embryos from both control and double morula-P10 aggregates were recovered 
at a reasonable rate in these aggregations also. The double morula control 
embryos were all developing normally and five of these ten control embryos 
appeared to be equivalent to embryos developing from transferred single morulae 
at 10.5 days development. The neural tube was fully closed and body development 
had reached the limb bud stage, with an extensive array of somites. In the 
other five control embryos, some developmental retardation was noted, but all 
were properly formed and further along than retarded P10 aggregate embryos. The 
double morula-P10 aggregate embryos are described in Table 7. 
Table 6 Embryo recovery data following transfer of double morula-Pl0 
aggregates and double morula aggregate controls 
embryos transferred 
implants (% transferred) 
resorptions (% implants) 
embryos (% implants) 
double morula double morula-Pl0 
control aggregates aggregates 
16 
10 (62.51.) 
o 
10 (1001.) 
overall embryo recovery: 
24 
18 (751.) 
7 (39%) 
11 (611.) 
embryos recovered/embryos transferred 
controls: 62.51. double morula-Pl0 aggregates: 46% 
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TABLE 7 
Aggregations of a single Pl0 clump with 2 morulae 
Embryo and description 
1. misshapen head, little body 
development 
2. very small, badly formed 
3. badly formed, unfused 
allantois 
4. very small, badly formed 
5. neural tube open, unfused 
allantois, body development 
better 
6. small, neural tube open, 
unfused allantois, body 
development better 
7. small, neural tube open, 
unfused allantois 
8. small, better tube closure, 
poorer body development 
'9. no embryo, growth of tissue 
on yolk sac 
10. small, better tube closure, 
poorer body development, 
unfused allantois 
11. no embryo in yolk sac 
Embryo 
proper 
• 
• 
• 
• 
- + 
GPI Analysis 
Extraembryonic 
membranes 
() 
() 
() 
e + ys 
EPC: ectoplacental cone fraction of the conceptus 
The black portion of each diagram represents Pl0 contribution. 
EPC 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
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GPI analysis indicated that again all the embryos recovered were chimeric, 
and despite the relatively lower P10 component of the aggregates initially, P10 
contribution was very high by midgestation in each embryo. All the embryos had 
P10 contributions greater than 50%, and only one was judged to be less than 75% 
P10 derived. The other embryos were totally, or nearly totally P10 derived. In 
two cases, embryos and membranes were inseparable, but the remaining nine 
cleanly dissected membrane fractions were all chimeric and demonstrated a range 
of P10 contribution similar to that seen in the aggregates of a P10 clump with a 
single morula; that is, a marked decrease in P10 contribution to this fraction 
was not evident. The P10 cells did not colonize the ectoplacental cone fraction 
of any conceptus. 
These P10 chimeras were also badly formed, with the abnormalities generally 
following the trends seen previously. In three cases, body development was 
better than that usually seen, with limb buds and somites present, but in two 
other cases a recognizable embryo was not present. 
ld. Karyotyping of P10 cells 
Chromosome preparations were made from P10 cells which had been 
established in culture from frozen stocks from M. McBurney, and maintained in 
this laboratory for two months. This karyotype analysis was undertaken at the 
completion of this project. A total of 38 metaphase spreads were examined, 
and the chromosome count was found to vary between 39 (20 spreads) and 40 (18 
spreads). Obvious abnormalities such as major deletions or trans locations were 
not noted. Analysis of one G-banded spread containing 39 chromosomes revealed 
that a very large chromosome lacked a mate. The banding pattern in this 
chromosome matched the banding in the X chromosomes in the karyotype analyses 
published by Robertson, et~. (1983) and this spread was assigned an XO 
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Plate 3 Chromosome preparations from P10 cells 
An example of an XO genotype. 
A A G-banded spread containing 39 chromosomes. 
B These chromosomes were enlarged for a karyotype analysis. The large 
chromosome identified as an X chromosome had no mate. 
8b 
A 
Plate 4 Chromosome preparation from P10 cells 
A A G-banded spread containing 40 chromosomes. 
B These chromosomes were enlarged for a karyotype 
analysis. Although the banding is faint, each 
chromosome appears to have mate. 
87 
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genotype. Analysis of a spread containing 40 chromosomes suggested that two 
X chromosomes were present (plates 3 and 4). 
2. Aggregations of P19 cells with morulae 
2a. Aggregations of a P19 clump with a morula 
In these experiments, P19 clumps were aggregated with morulae and the 
outcome was compared to Pl0 aggregations. An initial difference was noted in 
that P19 clumps were less "sticky" than Pl0 clumps from suspension cultures and 
were more difficult to aggregate with morulae. However, with several 
adjustments to the aggregates, better than 80% of these attempts were eventually 
successful, as were Pl0 aggregation attempts. The following day, Pl0-morula 
aggregates appeared to be well integrated morulae, in which the Pl0 clump could 
not be distinguished. The P19-morula aggregates did not generally appear to be 
so well integrated, and the P19 clump could usually still be recognized. 
A more dramatic difference was noted following transfer of P19-morula 
aggregates to recipients. Embryo recovery data at 10.5 days development is 
given in Table 8 and compared to Pl0-morula aggregate embryo recovery at a 
similar stage. 
While the P19-morula aggregates implanted in the uterus at a comparable 
rate to Pl0-morula aggregates, a very high percentage of these aggregates 
resorbed early such that embryo recovery at 10.5 days development was very low. 
The six embryos which were recovered are described in Table 9. These embryos 
were all judged to be developing normally, and GPI analysis revealed that these 
embryos were not chimeric. The P19 cells did not contribute to any fraction of 
the conceptus. 
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Table 8 Comparison of P19-morula aggregate embryo recovery to Pl0-morula 
aggregate embryo recovery 
Pl0-morula P19-morula 
aggregates aggregates 
embryos transferred 41 48 
implants (i. transferred) 29 ( 71i.) 33 ( 69i.) 
resorptions (i. imp lants) 7 ( 24i.) 27 (82i.) 
embryos (5 implants) 22 (76i.) 6 (18i.) 
overall embryo recovery: 
embryos recovered/embryos transferred 
Pl0-morula aggregates: 54% P19-morula aggregates: 12.5% 
TABLE .2 
Aggregations of a single P19 clump with a ,_morula 
Embryo and description GPI Analysis 
1- Normal 
2. Small, 
3. Small, 
4. Small, 
5. Normal 
6. Normal 
but normal 
but normal 
but normal 
Embryo 
proper 
Extraembryonic 
membranes 
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EPG 
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2b. Aggregations of retinoic acid pretreated P19 cells with morulae 
In the first experiments of this type, the P19 cells were pretreated for 
24 hours with retinoic acid in a monolayer culture, then for an additional 24 
hours in a suspension culture. The P19 clumps in these cultures were not the 
well-integrated cell aggregates resembling ICMs which EC cells usually form in 
suspension culture. Instead, these cell clumps appeared to have cells on the 
surface which were less well integrated with the rest of the clump. These P19 
clumps treated for a total of 48 hours with retinoic acid did not aggregate well 
with morulae. In 32 aggregation attempts, in two experiments, only five 
P19-morula aggregations were judged successful the following day. When RA 
pretreatment was decreased to 24 hours (in suspension culture), the P19 clumps 
from the suspension cultures were "sticky" and could be aggregated with morulae 
much more readily than those which had received the longer treatment. Embryo 
recovery data at 10.5 days gestation following transfer of these 24 hr RA+ 
P19-morula aggregates is compared to recovery of the untreated P19-morula 
aggregates at a similar stage in Table 10. 
A better rate of embryo recovery was seen following pretreatment of the P19 
cells with retinoic acid, but the early resorption rate was still very high, at 
64%. The nine embryos recovered following treatment of the P19 cells with 
retinoic acid are described in Table 11. All these embryos were judged to be 
developing normally, and again CPI analysis indicated that these embryos were 
not chimeric. 
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Table 10 Comparison of untreated P19-morula aggregate embryo recovery 
to 24 hr RA+ P19-morula aggregate embryo recovery 
untreated P19- 24 hr RA+ P19-
morula aggregates morula aggregates 
embryos transferred 48 29 
implants (% transferred) 33 (69%) 25 ( 861.) 
resorptions (1. implants) 27 ( 821.) 16 ( 641.) 
embryos (% implants) 6 ( 181.) 9 ( 361.) 
overall embryo recovery: 
embryos recovered/embryos transferred 
untreated P19-morula aggregates: 12.5% 
24 hr RA+ P19-morula aggregates: 31% 
TABLE II 
Aggregations of P19 clumps treated 24 hours with 
retinoic acid with morulae 
Embryo and description GPI Analysis 
Embryo Extraembryonic 
P..£QPer membranes 
1. Normal 0 8 0 2. Normal 
J. Slightly small, but normal 0 0 
4. Slightly small, but normal § 0 5. Slightly small, but normal 6. Small, but normal 
7. Small, but normal 8 8. Small, but normal 9. Small, but normal 0 
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EPC 
0 § 
8 
0 
8 
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2c. Injections of P19 cells treated 48 hours with retinoic acid into blastocysts 
Since P19 cell clumps treated 48 hr with retinoic acid could not be 
aggregated with morulae, they were injected into blastocysts. The embryo 
recovery data at 9.5 to 14.5 days gestation and the descriptions of the embryos 
recovered following the injections are given in Table 12. 
Embryo recovery was very high following injection of the treated P19 cells 
into blastocysts, and the great majority of these embryos were developing 
normally at midgestation and beyond. Again, the retinoic acid pretreated P19 
cells had not contributed to any fraction of any conceptus. 
2d. Cells outgrowing from P19 clumps following RA treatment 
In order to monitor in vitro the effects of 24 hr and 48 hr retinoic acid 
treatments on the P19 cells, P19 cell clumps were plated out from treated and 
untreated suspension cultures. Untreated P19 cell clumps formed colonies of EC 
cells. At the periphery of these a few large flat cells were observed by the 
second day of culture. These differentiated cells morphologically resembled 
extraembryonic endoderm cells. The dense EC colonies began to degenerate quite 
rapidly after two days in culture, while the differentiated cells continued to 
proliferate. 
When clumps of P19 cells treated with retinoic acid for 24 or 48 hr were 
plated out from suspension cultures, a much greater degree of differentiation 
was evident by the second day. The dense central areas of the colonies may have 
harbored undifferentiated EC cells but it was difficult to make a positive 
identification of EC cells by their morphology alone (plates 5 and 6). 
The clumps plated out in the above experiments were a heterogeneous mixture 
of sizes. In subsequent experiments, small clumps, the size of those aggregated 
with morulae or injected into blastocysts, were selected from the suspension 
Table 12 Embryo recovery following injection of P19 cell clumps 
treated 48 hr with retinoic acid into blastocysts 
injected blastocysts 
transferred 
36 
Embryo descriptions: 
27 normal embryos 
implants 
(% transferred) 
32 (8970) 
1 retarded embryo on the yolk sac 
1 empty yolk sac 
resorptions 
(70 implants) 
embryos 
(70 implants) 
3 (970) 29 (91%) 
GPI Analysis: 
ALL EMBRYOS 
NON-CHIMERIC 
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Plate 5 Retinoic acid induces differentiation of P19 cells in vitro 
A An untreated culture of P19 cells, plated out after 24 hr in 
suspension culture, and stained 2 days after plating. The culture 
consists primarily of EC colonies, although spontaneously 
differentiated cells (arrows) can be seen at the peripheries. 
B P19 cells plated out after 48 hr retinoic acid treatment. 
A high level of differentiation is evident within only 24 hr after 
plating. 
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A 
B ' 
Plate 6 Undifferentiated EC cells may persist despite retinoic acid 
pretreatment. 
A An untreated P19 culture, plated out after 24 hr in suspension 
culture and stained 2 days after plating. Higher magnification 
of a colony with differentiated cells at the periphery. 
B P19 cells treated 24 hrwith retinoic acid and stained 2 days 
after plating from suspension culture. While extensive 
differentiation is evident, EC cells might persist in the dense 
central regions of the colonies. 
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A 
B 
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cultures and plated out. When small, untreated lumps were plated out, 
undifferentiated EC cells were the only cells present in most outgrowths after 
two days. When small RA treated clumps were plated out, a high level of 
differentiation was evident in these outgrowths by Day 2. However, cells with 
an EC-like morphology were clearly present in most. In 19 outgrowths from these 
small P19 clumps treated 48 hr with retinoic acid, 18 contained a small central 
focus of EC-like cells, surrounded by differentiated cells of an unknown type 
(Plate 7). 
2e. Immunofluorescence assays 
These experiments were designed to positively identify undifferentiated EC 
cells persisting in RA treated P19S1801Al cultures. When small clumps of 
untreated 01Al cells were plated out from suspension cultures, the colonies 
appeared EC-like after two days, and fluorescence of entire colonies was 
observed. Following a 24 hr or 48 hr retinoic acid pretreatment, a high level 
of differentiation was evident in Day 2 outgrowths from small clumps. But 
clusters of cells with an EC-like morphology could be identified within these 
outgrowths, and these cells fluoresced, while the cells with a differentiated 
morphology did not (Plate 8). These EC-like cells, and the untreated 
cultures did not 
fluoresce in the absence of anti-SSEA-l in controls to which only the 
fluorescein tagged anti-IgM antibody was added. 
2f. ~ vitro outgrowths of untreated or RA treated P19-morula aggregates 
These experiments differ from those just described in that the untreated or 
RA treated P19 cells were aggregated with morulae and the aggregate embryos were 
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outgrown in vitro. P19S18D1Al (D1Al) cells, which are hypoxanthine 
phosphoribosyl transferase negative (HPRT-), were used such that embryo derived 
cells in the aggregate outgrowths could be positively identified as the labelled 
cells in autoradiograms. 
When untreated D1Al-morula aggregates were outgrown and labelled with 
[3H}hypoxanthine, EC-like cells were usually, but not always, present. Most 
commonly, a heavy growth of EC-like cells predominated (Plate 9). These cells 
were unlabelled in the autoradiograms, as were other cells with a 
differentiated morphology present in these outgrowths. Labelled giant cells 
could be found, and occasionally a patch of labelling could be seen within the 
EC-like growth. This was the presumptive ICM of the embryo. In six such 
autoradiograms, five matched the above description, while in one, no cells with 
an EC-like morphology were seen. In this outgrowth, only a group of 
undifferentiated, unlabelled cells were present, off to the side of a normal 
appearing blastocyst outgrowth. 
When the D1Al cells were pre-treated for 24 hr with retinoic acid prior to 
aggregation with morulae and outgrowth, the unlabelled cells with the EC-like 
morphology were observed again in most outgrowths. In seven such outgrowths, 
four contained a growth of EC-like cells which usually appeared to be integrated 
with the embryonic ICM. The unlabelled differentiated cells present in these 
outgrowths usually appeared scattered, and not associated with the ICM and 
EC-like cells. In one other outgrowth, only these differentiated cells were 
present in addition to the embryonic cells, and in two others no EC or 
EC derived cells could be seen. These appeared to be normal blastocyst 
outgrowths. 
The in vivo and in Yi!IQ P19 results are summarized in Tables 13a and 
13b. In Table 13b, the numbers refer to outgrowths established in chambered 
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slides. Additionally, cells were plated out from suspension cultures into petri 
dishes in all experiments involving retinoic acid treatment, and EC like cells 
were always seen. 
Plate 7 Further evidence that EC-like cells persist despite 
retinoic acid treatment 
A A blastocyst outgrowth from a 24 hr RA+ P19(OlAl)-morula 
aggregate. The embryonic trophectodermal giant cells (central) 
are surrounded by a massive growth of EC-like cells, which 
were not labelled in autoradiograms, and therefore were not 
of embryonic origin. 
B Foci of EC-like cells (arrow) could be found in most outgrowths 
from small clumps of P19 cells (the size of those aggregated 
with morulae or injected into blastocysts) even after a 48 hr 
pretreatment with retinoic acid. 
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Plate 8 Positive identification of undifferentiated EC cells 
in retinoic acid treated P19 cultures 
A P19 cells express SSEA-l. Fluorescence of an entire colony of 
untreated P19 cells, with an EC-like morphology, in an indirect 
immunofluorescence assay utilizing anti-SSEA-l as the primary 
antibody. 
B Undifferentiated EC cells persist, despite retinoic acid treatment. 
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Fluorescence of a small cluster of EC-like cells in a culture 
treated 48 hr with retinoic acid. Cells with a differentiated 
morphology (seen faintly in the background) did not bind anti-SSEA-l. 
The assays were performed 48 hr after plating small cell clumps 
from suspension cultures. 
/06 
A 
B 
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Table 13a Embryo recovery data following incorporation of P19 cells 
untreated 24 hr RA+ 48 hr RA+ 
P19-morula P19-morula P19 injected 
aggregates aggregates blastocysts 
embryos transferred 48 29 36 
implants ("I. transferred) 33 ( 69"1.) 25 ( 86"1.) 32 ( 89"1.) 
resorptions ("I. implants) 27 ( 82"1.) 16 ( 64"1.) 3 ( 9"1.) 
embryos (% implants) 6 (18"1.) 9 (36%) 29 (91%) 
"I. embryos normal 100 100 93 
"I. embryos chimeric 0 0 0 
Table 13b IN VITRO: 
- -
Persistence of undifferentiated P19 cells in outgrowths 
Outgrowth description 
untreated P19 cell clumps 
24 hr RA+ P19 cell clumps 
48 hr RA+ P19 cell clumps 
untreated P19-morula 
aggregates 
24 hr RA+ P19-morula 
aggregates 
48 hr RA+ P19-morula 
aggregates 
48 hr RA+ P19 injected 
blastocysts 
Persistence of undifferentiated EC cells in 
Day 2 outgrowths 
detected by 
morphology 
8/8 
8/8 
18/19 
5/8 
4/7 
aggregation 
unsuccessful 
confirmed by 
immunofluorescence 
6/6 
2/2 
2/2 
confirmation by 
autoradiography 
5/6 
4/7 
not determined, all blastocysts 
transferred to recipients 
108 
II AGGREGATIONS OF ICMs WITH MORULAE 
1. In ~ development of ICM-morula aggregates 
These experiments were designed to test the effects of aggregating normal 
embryonic cell types, from two different developmental stages. In these 
experiments either a single inner cell mass (ICM) isolated from a 3.5 day 
blastocyst, or three such ICMs were aggregated with single 2.5 day morulae. 
Embryo recovery at 9.5 to 12.5 days gestation is given in Table 14. 
Aggregate embryos containing ICM cells demonstrated a high rate of 
resorption not shared by the control morulae in these experiments. As the 
number of ICM cells in the aggregate was increased, the resorption rate also 
increased. 
The ICM-morula aggregates which escaped early resorption and were recovered 
around midgestation (9.5 to 12.5 days) are described in Table 15. Embryos 
developing from single ICM-morula aggregates were all judged normal. Some of 
these embryos were left to develop longer than usual and were recovered at 12.5 
gestation. They were as well developed as control fetuses at this stage. 
Considerable variation was noted in the extent of colonization of the 
embryos by the added ICM cells (Table15). Five of the 13 embryos were not 
chimeric, and in four of these the added ICM cells had not colonized the 
membrane fraction either. In #10, the added ICM cells had colonized the 
membranes only. The other eight embryos were chimeric, with contributions 
ranging from about 40% to 100%. In each case where the added ICM cells had 
colonized the embryo fraction, they had also colonized the membranes, with 
contributions also ranging from 40% to as high as 100%. Small amounts of BB 
isozyme were detected in several of the ectoplacental cone fractions. 
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Table 14 Embryo recovery data following transfer of ICM-morula aggregates 
control ICM-morula 3ICM-morula 
morulae aggregates aggregates 
embryos transferred 65 48 36 
implants (7. transferred) 43 ( 667.) 34 ( 717.) 23 ( 647.) 
resorptions (7. implants) 7 (16%) 21 ( 627.) 20 (877.) 
embryos (% implants) 36 ( 847.) 13 (38%) 3 ( 137.) 
overall embryo recovery: 
embryos recovered/embryos transferred 
controls: 55% 
ICM-morula aggregates: 27% 
3ICM-morula aggregates: 8% 
TABLE 1..S. 
Aggregations of ICMs with a morula 
Aggregations of 1 ICM with a morula 
Embryo and description 
1. Normal 
2. Normal 
.3. Normal 
4. Normal 
5. Normal 
6. Normal 
7. Normal 
8. Normal 
9. Normal 
10. Normal 
11. Normal 
12. Normal 
1.3. Normal 
Aggregations 
1. Normal 
of 1 
2. Disorganized, 
allantois 
.3. Normal 
ICMs with 
unfused 
a 
Embryo 
proper 
morula 
---
• () 
e 
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GPI Analysis 
Extraembryonic 
membranes 
• () 
--
EPC: ectoplacental cone fraction of the conceptus 
The black portion of each diagram represents contribution 
by the added ICM cells. 
EPC 
(!) 
() 
0 
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Two of the three embryos recovered following aggregation of three ICMs with 
a morula were developing normally, but one embryo was clearly abnormal at 9.5 
days development. This was a small embryo, with recognizable head fold and 
heart regions. The rest of the body appeared disorganized, with no recognizable 
somites, and an unfused allantois. The two normal embryos were very chimeric, 
as were their membranes. The abnormal embryo was difficult to dissect due to 
its small size, but was a chimera. 
2. Substitution of egg culture media for 0{ tissue culture medium 
2a. Development of early embryos in various culture media 
The ICM-morula aggregates just described were cultured overnight in 
medium prior to transfer. In order to determine whether the high early 
rsorption rate seen was due to culture conditions, various egg (embryo) culture 
media were substituted. These defined media were devised to promote the growth 
of single and 2-cell embryos in vitro. Two egg culture media, one devised by 
Whitten ( Biggers, ~ al., 1971) and the other by Brinster (Cross and Brinster, 
1973) were selected. The compositions of these media and details of their 
preparation are given in Appendix 1. 
In preliminary tests, the abilities of these media to support in vitro 
development of control embryos were compared. In the first test, embryos were 
collected at the 8-cell stage and cultured inot, Whitten's and Brinster's 
media. As shown in Table 16, blastocyst formation was somewhat delayed in both 
egg culture media. 
In a second test, embryos were collected at the 2-cell stage, and cultured 
in both Brinster's and Whitten's media. The outcome is given in Table 17. 
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Table 16 Timing of blastocyst formation when 8-cell embryos 
were cultured in various media 
Day 1 medium Brinster's Whitten's 
Blastocysts 7 0 0 
Cavititation 4 5 5 
beginning 
Late morulae 7 4 1 
+ 2 dying 
embryos 
Day 2 
Blastocysts 18 9 6 
Cavitation 0 0 0 
beginning 
Late morulae 0 0 0 
+ 2 dead 
embryos 
Table 17 Timing of blastocyst formation when 2-cell embryos 
were cultured in various media 
2-cell 4-cell 6-cell 
Day 1 
Brinster's 0 6 1 
Whitten's 0 1 o 
Day 2 
Brinster's 0 2 o 
Whitten's 0 o o 
Day 3 
Brinster's 0 1 1 
Whi tten' s 0 o o 
8-cell 
o 
5 
o 
o 
o 
o 
compacted 
morulae 
o 
1 
5 
6 
3 
o 
bias tocys ts 
o 
o 
o 
1 
2 
7 
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Development of these embryos from the 2-cell stage proceeded somewhat more 
rapidly in Whitten's medium, and all the embryos underwent successful blastocyst 
formation in this medium. These blastocysts appeared healthy and were 
subsequently transferred to a tissue culture surface where they formed normal 
blastocyst outgrowths. 
2b. Subsequent in utero development of triple rCM-morula aggregates cultured in 
Whitten's medium during the preliminary in vitro period 
Following the observation that early embryos developed best in vitrg when 
cultured in Whitten's medium as opposed to Brinster's, this medium was chosen to 
test the effect of varying the in vitro conditions on subsequent development of 
rCM-morula aggregates. Control embryos and triple rCM-morula aggregates were 
transferred to recipients following 24 hr !a ~ culture in this medium. The 
outcome of these experiments is given in Table 18. Embryo recovery at 10.5 days 
gestation following culture of control morulae in Whitten's medium was 
comparable to that seen following culture in ~ medium. When 3rCM-morula 
aggregates were cultured in Whitten's medium prior to transfer, embryo recovery 
was still very low, but four embryos were recovered. All four appeared to be 
developing normally. One of these was as large and as well developed as the 
controls, and this embryo and its membranes were nearly completely derived from 
the added rCM cells. The other three embryos were very small at 10.5 days 
development, and the spots on the GPr analysis gels were faint, but these 
embryos were chimeras also. 
Although no obvious difference was seen in embryo recovery following 
culture of the aggregates in Whitten's medium rather than~ medium, the low 
embryo recovery was due in this case primarily to a failure of these aggregates 
to implant in the uterus following culture in Whitten's medium. This difficulty 
Table 18 
A COMPARISON OF EMBRYO RECOVERY FOLLOWING CULTURE IN ~ MEDIUM VS WHITTEN'S MEDIUM 
Description of Embryos Implants 
Embryos Transferred (~ transferred) 
Control morulae 
cultured in 128 97 (76%) 
0(. medium 
3ICM-morula aggregates 
cultured in~ medium 36 23 (64%) 
Control morulae 
cultured in Whitten's )6 23 (64%) 
medium (2 experiments: 
5 recipients) 
3ICM-morula aggregates 
cultured in Whitten's 23 7 (Jo%) 
medium 
Resor12tions 
(~ im12lants) 
17 (17.5%) 
20 (87%) 
3 (13%) 
3 (43%) 
Embryos 
(~ transferred) 
80 (62.5%) 
3 (8%) 
20 (55.5%) 
4 (17%) 
~ 
~ 
~ 
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was not shared by the controls cultured in this medium nor by aggregates 
cultured in~ medium. 
III Comparison of ICM-morula aggregate development to EC-morula aggregate 
development 
1. In vitro development of aggregates 
la. Status of embryos following overnight in vitro culture 
Aggregates were always cultured overnight in vitro prior to transfer to 
allow for the formation of a well integrated aggregate morula at a stage 
suitable for transfer to the recipient uterus. The status of aggregate embryos 
was assessed prior to transfer, following the overnight in vitro culture period. 
The status of ICM-morula aggregates is compared to controls and Pl0-morula 
aggregates in Table 19. 
The histogram in Figure 8 compares the percentages of embryos in which 
blastocoele formation was at least detectable following the overnight culture 
period for the different types of aggregate embryos. 73% of control morulae, 
collected at the 8-cell stage the day previous and cultured overnight, had at 
least reached the late morula stage in which cavitation was detectable, and more 
than half of these were already blastocysts. The onset of cavitation was 
delayed in aggregates to which ICM or Pl0 cells had been added, with the 
addition of a single ICM having the least effect. 
Where further development was to be assessed in ~, the embryos were 
transferred at this stage. In other experiments, embryos were allowed to 
proceed to the blastocyst stage in vitro by culturing a further 24 hr. 
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Table 19 Status of embryos following overnight in ~ culture 
Late morulae Cavitation Blastocysts 
detectable 
Controls 2770 (93/341) 2870 (96/341) 4570 (152/341) 
rCM-morula 5870 (63/108) 9io (10/108) 3270 (35/108) 
aggregates 
3rCM-morula 85.570 (71/83) 1170 (9/83) 3.570 (3/83) 
aggregates 
Pl0-morula 8570 (77/91) 1270 (11/91) 3'70 (3/91) 
aggregates 
3Pl0-morula 9n (68/70) 370 (2/70) 0 
aggregates 
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FIGURE 8 
STATUS OF EMBRYOS FOLLOWING OVERNIGHT IN VITRO CULTURE 
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lb. Blastocyst formation ~ Yi1I2 
In 23 cases where triple ICM-morula aggregates were cultured 48 hr i£ vitro 
only one of the blastocysts which developed was considered to be morphologically 
normal when compared to control blastocysts. The unusual blastocysts exhibited 
a disproportionately large ICM (Plate 9). In other cases, the embryos 
barely resembled blastocysts and little evidence of trophectoderm formation was 
noted. However, when these unusual blastocysts were outgrown on tissue culture 
surfaces, giant cell differentiation was always evident. 
In 17 cases where single ICM-morula aggregates were cultured 48 hr in 
~, seven blastocysts were judged to be morphologically normal, while the 
remainder had disproportionately large ICMs or unusual forms. Therefore, 
while the deviations from normal form were not as severe in this group, the 
majority of blastocysts were considered to be unusual. 
P10-morula aggregates develop into large but normal blastocysts in vitro. 
In 23 cases where single P10-morula aggregates and 21 cases where triple 
P10-morula aggregates were cultured to the blastocyst stage in Yi!!9, only two 
blastocysts were considered to be morphologically abnormal. 
As already described, P19-morula aggregates generally do not form well 
integrated aggregate morulae in the overnight culture period. However, with 
further ~E. vi~2 culture, these aggregates also develop into morphologically 
normal blastocysts (Plate 9). It is possible that some P19 cells may 
remain scattered on the outer surface of the trophectoderm. 
Blastocyst formation by triple ICM-morula aggregates was also tested in 
the egg culture media. The blastocysts which developed from six such aggregates 
in Brinster's medium were unusual and comparable to those which formed in 
medium. When 3ICM-morula aggregates were cultured in Whitten's medium, the 
blastocysts which developed generally had a more normal appearance. Eleven 
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morphologically normal and only two unusual blastocysts developed from 13 
aggregates cultured in Whitten's medium. The in vitro blastocyst formation 
results are summarized in Table 20. 
lc. Blastocyst formation in utero 
It must be stressed that when blastocyst formation was to be assessed ilL 
~ro, the embryos were cultured a total of 48 hours, whereas in experiments 
where embryos were transferred to recipients, the UL~ culture period was 
24 hr only. As shown already in the histogram, most aggregate embryos are 
transferred at the late morula stage, and blastocyst formation takes place in 
the recipient uterus. In order to compare the blastocysts which develop from 
transferred 3ICM-morula aggregates in the uterus to those which develop in 
vitro, recipient uteri were flushed the day following embryo transfer. In two 
such experiments seven embryos were recovered following transfer of ten 
3ICM-morula aggregates, and these all appeared to be normal late blastocysts 
which were about to implant in the uterus (Plate 9). That is, these 
blastocysts did not resemble the morphologically unusual blastocysts which 
developed when 3ICM-morula aggregates were cultured to the blastocyst stage in 
vitro. (Since EC-morula aggregates formed normal blastocysts ill vitro, similar 
early recovery experiments were not done with these aggregates.) 
Plate 9 Blastocyst formation from aggregates 
A A blastocyst which developed in Yi1!2 in ~ medium from 
a control morula. 
B A morphologically unusual blastocyst which developed 
i!! vi tro in 0<. medium from a triple rCM-morula aggregate. 
C A morphologically normal blastocyst which developed 
in. vi tro in Whi tten' s medium from a triple rCM-morula 
aggregate. 
D Morphologically normal, late blastocysts flushed from 
the recipient uterus 24 hr after transfer of 3rCM-morula 
aggregates cultured inC< medium for only 24 hr prior to 
transfer. 
E A morphologically normal blastocyst which developed in 
y'!!!'o in-=-< medium from a 3Pl0-morula aggregate. 
F Blastocysts which developed i!!.. Yilli in~ medium from 
P19-morula aggregates. P19 cells may be scattered on the 
outer surface of the trophectoderm. 
The blastocysts which developed in ~ were photographed 
following 48 hr cutlure beyond the 2.5 day morula stage. 
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Table 20 Blastocyst formation in vitro 
Aggregate type 
lCM-morula (in~) 
3lCM-morula (inoe) 
Embryos cultured 
to blastocyst 
stage in vi tro 
17 
23 
3lCM-morula (Whitten's) 13 
Pl0-morula 23 
3Pl0-morula 21 
P19-morula 9 
Morphologically 
unusual 
blastocysts 
10 
22 
2 
1 
1 
o 
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2. Histological examinations of early post implantation development of 
EC-morula and 3ICM-morula aggregates 
2a. 6.5 day histology 
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Ten implantation sites from two recipients of 3ICM-morula aggregates were 
examined at 6.5 days development. Eight of these sites contained debris only in 
the uterine crypt, while two embryos (one from each recipient) were recovered. 
These embryos were small and less well developed than controls at 6.5 days, but 
were apparently normal (Plate 10). 
The development of Pl0-morula aggregates and P19-morula aggregates was 
examined at earlier stages for comparison with the ICM-morula histology. Eight 
3Pl0-morula aggregate implantation sites were recovered following transfer of 15 
aggregates to three recipients. In contrast to the ICM-morula aggregates, only 
two resorption sites were found at 6.5 days. An embryo had not developed in one 
implantation site, while the remaining five contained embryos. Four of these 
were small and gross abnormalities were not yet apparent. In one, a clearly 
abnormal embryo was present (Plate 11). In this embryo, the folding of 
the two primary germ layers is abnormal, such that two cavities appear to be 
forming, and the extraembryonic ectoderm appears somewhat deficient. 
Five P19-morula implantation sites from one recipient were examined at 6.5 
days. One embryo was found, which appeared normal. Two other sites were 
resorbing, while two more did not contain a recognizable embryo. One of these 
crypts is shown in Plate 11. A few giant cells can be found, as well as 
small round cells in the crypt which may be P19 cells. 
2b. 5.5 day histology 
Because both the ICM-morula and P19-morula aggregates were resorbing in 
large numbers before day 6, some of these embryos were examined at 5.5 days 
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development also. 
Nine 3ICM-morula aggregates were transferred to two recipients in order to 
assess development at 5.5 days. Seven implantation sites were recovered. A 
variety of abnormalities were seen, ranging from various degrees of retardation 
in four small but apparently properly organized embryos, to poorly organized 
embryos, to one case in which only a few parietal endoderm cells could be 
identified within the trophoblast (Plate 11). 
Eight P19-morula implantation sites were recovered at 5.5 days following 
transfer of ten aggregates to two recipients. These embryos generally did not 
develop even to the early egg cylinder stage. In six, a recognizable 
embryos could not be found, while two implantation sites contained small 
embryos. 
The histological findings are summarized in Table 21. 
Plate 10 6.5 day histology of 3ICM-morula aggregates. 
A A 6.5 day egg cylinder stage embryo developing from a 
transferred control morula. The embryo is at a stage 
of development comparable to the embryo diagrammed in 
Figure 2. 
B An embryo developing from a 3ICM-morula aggregate at 
6.5 days. While the form is overtly normal, the embryo 
is considerably retarded. 2 such embryos were found in 
10 implantation sites. 
C The remaining 8 implantation sites contained debris, 
indicating that the majority of 3ICM-morula aggregate 
embryos had died by 6.5 days. 
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(2.b 
Plate 11 Examples of early abnormal development of ICM 
and EC containing aggregates. 
A A 5.5 day implantation site in which a 3ICM-morula 
aggregate had implanted. A properly organized egg cylinder 
has not developed. A few parietal endoderm cells can be 
identified (arrows). 
B A 6.5 day implantation site containing an embryo developing 
from a 3Pl0-morula aggregate. The folding of the embryonic 
tissue is unusual, such that 2 cavities are forming. 
C A 6.5 day implantation site in which a P19-morula aggregate 
had implanted. An egg cylinder has not developed. A few 
scattered embryonic giant cells can be identifed (white arrows). 
The small round cells (black arrow) within the crypt may be 
P19 cells. 
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Table 21 Summary: Histological examinations 
6.5 days implant sites normal abnormal resorptions 
examined embryos development 
3ICM-morula aggregates 10 2 ( small) 0 8 
3P10-morula aggregates 8 4 (small ) 2 2 
P19-morula aggregates 5 1 2 2 
5.5 days 
3ICM-morula aggregates 7 4 (small) 3 0 
3P10-morula aggregates 
P19-morula aggregates 8 2 (small) 6 0 
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3. Comparison of embryo recovery following transfer of rCM-morula aggregates 
and P10-morula aggregates 
Embryo recovery at midgestation of rCM-morula aggregates is compared to 
P10-morula aggregate recovery in Table 22. 
Recovery of embryos at midgestation was much higher for P10-morula 
aggregates compared to recovery of embryos from rCM-morula aggregates. Although 
these P10 chimeric embryos were abnormal, they survived until at least 
midgestation, and recovery of embryos from P10-morula aggregates was not 
decreased as the number of P10 cells in the aggregate was increased. 
These data have been subjected to statistical analysis by a ?(~test (see 
Appendix 2). The differences between resorption rate~ of control morulae and 
P10 containing aggregate embryos are probably not significant (p=<0.50 and > 
0.20). The differences between resorption rates of control morulae and rCM 
containing aggregates are highly significant however (p=«0.001). 
TABLE 22 
EMBRYO RECOVERY DATA 
Descri:Qtion Embryos Implants 
of embryo transferred <if transferred) 
Control 128 97 (76%) morulae 
Aggregate: 
Pl0 clump + 41 29 (71%) 
a morula 
Aggregate: 
3 Pl0 clumps + 31 23 (74%) 
a morula 
Aggregate: 
single ICM + 48 34 (71%) 
a morula 
Aggregate: 
3 ICMs + 36 23 (64%) 
a morula 
Resor:Qtions (2f im:Qlants) 
17 (17.5%) 
7 (24%) 
6 (26%) 
21 (62%) 
20 (87%) 
Embryos (2f implants) 
80 (82.5%) 
22 (76%) 
17 (74%) 
13 (38%) 
3 (13%) 
....... 
IuJ 
....... 
132 
DISCUSSION 
I The behavior of karyotypically normal EC cells in EC-embryo aggregation 
chimeras 
Until this study, aggregations of fully euploid EC cells with morulae had 
not been made. McBurney's Pl0 and P19 EC cell lines seemed to be very promising 
candidates for a test of the ability of karyotypically normal EC cell lines to 
form aggregation chimeras. Their potential to colonize the embryo following 
blastocyst injection has been fully explored (Rossant and McBurney, 1982 and 
1983) and Pl0 cells demonstrated considerable success in reverting to a normal 
embryonic phenotype in the blastocyst environment. It was predicted that 
following aggregation of Pl0 cells with 8-cell embryos, chimeras might be 
generated at an even higher frequency, and the Pl0 cells might predominate in at 
least some of these chimeras such that the ~ ~ developmental potential of 
this EC cell line could be more completely assessed. These two predictions 
concerning colonization of the embryo by EC cells following aggregation with 
morulae were borne out by the behavior of the Pl0 cells in this study. Pl0 
cells colonized the aggregate embryos very successfully such that all the 
embryos recovered at midgestation were chimeric. Therefore, just as Pl0 has 
been the most successful EC line to colonize the embryo following blastocyst 
injection, it has now demonstrated the greatest capacity for producing chimeras 
following aggregation, exceeding the 79% chimeric embryo recovery rate (at 
midgestation) reported by Fujii and Martin following aggregation of PSA-l/NG2 
cells with morulae. Secondly, each chimera recovered at midgestation exhibited 
a very high Pl0 contribution. Several embryos were totally, or almost totally 
Pl0 derived. However, such high levels of Pl0 contribution were incompatible 
with normal development. The only normal embryo recovered (#4 in Table 3) was 
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the only chimera with .a Pl0 contribution of less than 50%. In the previous 
blastocyst injection experiments the live born chimeras never demonstrated a 
predominant Pl0 derived cell population, and the more highly chimeric embryos 
were obviously developing abnormally at midgestation. The results from these 
aggregation experiments lend considerably more support to the hypothesis that a 
majority population of normal embryonic cells may be required in an EC-embryo 
chimera to provide a proper developmental framework. 
Fairly high numbers of Pl0 cells (15 to 20) were aggregated with each 
8-cell embryo in the first series of experiments. Because it had been 
demonstrated already that the embryo could sometimes regulate this cell load 
following blastocyst injection, it was not unreasonable to begin by aggregating 
a similar number of Pl0 cells with morulae. It has been suggested that the 
regulatory capacity of the embryo decreases as the number of EC cells added is 
increased (Martin, 1980; Pierce, et al., 1979; Illmensee and Stevens, 1979; 
Dewey, ~ ~., 1977). In order to test for a dose-response relationship between 
the number of Pl0 cells aggregated and the degree of abnormality, the effect of 
increasing the number of Pl0 cells present in the aggregate at the outset was 
first examined by aggregating three ICM-sized clumps of Pl0 cells with each 
embryo. Despite the imposition of this much larger EC load on the embryos, 
development was no worse. Survival time of these chimeras did not decrease, nor 
did the degree of overt abnormality increase. Their development was retarded 
relative to the first set of Pl0 chimeras, such that very small embryos were 
recovered at 9.5 days gestation, but they achieved a comparable stage of 
development by 11.5 days. The abnormal chimeras probably arrest around this 
stage of development and die shortly thereafter, judging by total resorption in 
two attempts to recover chimeras beyond 12.5 days. 
Interestingly, these very small 9.5 day embryos were less chimeric than the 
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embryos developing from the single Pl0-morula aggregates. By 11.5 days, 
however, these embryos were heavily chimeric. Initially Pl0 proliferation in 
the embryos may be relatively slow, such that Pl0 cells take over gradually in 
the developing chimeras. This hypothesis could be tested in a limited fashion 
by evaluating Pl0 contribution in developing chimeric embryos from even earlier 
stages, but it is unlikely that sufficient embryonic tissue would be present 
much earlier than 9 days for GPI testing without pooling embryos. The 
development of an in situ marker to distinguish EC derived cells in chimeric 
tissue would be more desirable. 
The effect of decreasing the Pl0 component of the aggregate at the outset 
was next tested. It has been suggested by the critics of high EC proportions 
that an embryo can be expected to regulate about three to five EC cells. 
Difficulties in aggregating such small numbers of EC cells were anticipated, 
primarily since the selection of undifferentiated Pl0 cells from mixed cultures 
of feeders, EC cells, and differentiated Pl0 cells depended on the morphology of 
ICM-like clumps of EC cells. Taking note that aggregating three to five EC 
cells with an 8-cell embryo would establish an EC to embryo cell ratio of 1:2, 
the usual clump of Pl0 cells, containing about 15 to 20 cells, was aggregated 
with two 8-cell embryos. Such an aggregate contained EC cells and embryonic 
cells in about equal proportions at the outset. A trend towards improved 
development was not noted. The embryos recovered at midgestation were just as 
chimeric, and just as abnormal as those in previous aggregations. Stewart 
(unpublished) recently aggregated only two or three Pl0 cells with two morulae, 
and while a few live born Pl0 aggregation chimeras were recovered (with Pl0 
contributions less than 50%) losses were still very high during gestation. The 
results from this study predict that the embryos lost were abnormal chimeras 
with predominant Pl0 populations. Apparently, Pl0 cells very successfully 
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colonize the embryo following aggregation with morulae such that varying the 
initial P10 proportion in the aggregate (from 6:1 to 1:1) does little to reduce 
the eventual colonization of the embryo and is of little importance, then, to 
the outcome at midgestation. 
The P10 cells did not colonize the extraembryonic membrane fraction to the 
same extent as the embryo proper. P10 contribution to this fraction never 
exceeded 50%, even in the embryos developing from triple P10-morula aggregates. 
Stewart (1982) also dissected conceptuses into their component fractions in his 
aggregation study. (The yolk sac has two components, extraembryonic endoderm 
and extraembryonic mesoderm, and these can be separated enzymatically by 13 days 
gestation.) Stewart found that EC cells often preferentially colonized the yolk 
sac mesoderm, and suggested that cultured EC cells require time to adjust to the 
embryonic environment and may not have differentiated endoderm. Since P10 
aggregation chimeras do not persist to 13 days, it was not possible to 
determine if these cells also preferentially colonize the yolk sac mesoderm 
following aggregation. However, Rossant has separated the yolk sac layers in 
the longer surviving blastocyst injection chimeras, and has also noted 
preferential colonization of the yolk sac mesoderm by P10 cells. She points put 
that P10 cells will form some endoderm in aggregates, and readily differentiate 
endoderm in response to retinoic acid. Cell cycle considerations may be 
important, then, during the integration of P10 cells into development. P10 
cells in culture clearly have a slower growth rate than other EC cell lines, 
such as P19 or PSA-l (Rosenstraus, et al., 1984) which exhibit doubling times of 
about 12 hr. Papaioannou, ~ al. (1978) point out that by 6.5 days development 
a proliferative burst occurs in the embryo (confirmed by Lewis and Rossant, 
1982) such that the average cell cycle time is 5 hr and cell cycle times as 
little as 2.5 hr are seen in certain regions. Therefore, they suggest that an 
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injected EC cell faces a considerable challenge in that it must shorten its cell 
cycle time fairly rapidly if it is to contribute significantly to a developing 
embryo. Aggregation of P10 cells with earlier 2.5 day embryos should have an 
advantage in this regard over injection into 3.5 day blastocycts. However, the 
cells may still not participate to an extensive degree in early developmental 
events such as primitive endoderm formation, which occurs shortly before 
implantation. By the time of mesoderm formation (about 3 days after 
implantation) they may have adjusted their cell cycles, allowing them to form 
mesoderm and eventually predominate in the embryos. The embryo probably becomes 
progressively more disorganised with increasing P10 participation, and while it 
survives the egg cylinder stage, it may not undergo proper organogenesis due to 
limitations in the ability of the P10 cells to direct normal development. 
P10 cells also did not contribute to the trophectoderm derived 
ectoplacental cone (epc) fraction of any conceptus beyond a trace in four 
samples. These trace contributions are most likely due to contamination by 
adherent membranes. Stewart saw no colonization of trophoblast tissue by his EC 
cell lines following aggregation, and Rossant saw trace contributions only to a 
few P10 injection chimera epc fractions. A similar explanation for the failure 
to colonize this fraction could be made. Trophectoderm formation occurs very 
shortly after aggregation, and has already occurred in blastocyst injection 
experiments, such that EC cells might not be expected to participate. But in 
light of the embryonic ectoderm origin of EC cells, it seems more likely that EC 
cells share the developmental restriction acquired by rCM cells; that is, they 
are no longer totipotent, but are determined cells which have lost the capacity 
to differentiate trophectoderm. 
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P19 is another diploid EC cell line, and the behavior of these cells in 
aggregation chimeras was compared to that of Pl0. Although the embryos were 
abnormal, Pl0 chimeras survived until midgestation. In striking contrast, 
P19-morula aggregate embryos resorbed in very high numbers prior to 
midgestation. The only embryos recovered were normal and non-chimeric. 
Previously, in blastocyst injection experiments, P19 cells also performed poorly 
compared to Pl0, but abnormal chimeric embryos were recovered at midgestation 
(Rossant and McBurney, 1982, 1983). Embryo loss was high after this time and 
the few live born chimeras had tumors. Rossant and Papaioannou (in press) have 
now compared the in vitro outgrowths of blastocysts injected with either Pl0 or 
P19 cells. EC cells grew out from most (62/72) blastocysts injected with P19 
cells but rarely (7/81) from blastocysts injected with Pl0 cells. These results 
suggest that P19 cells might not be regulated as well by the blastocyst. 
Perhaps they do not respond as well to signals to differentiate and instead 
persist as undifferentiated EC cells within the embryos. Was persistence of 
undifferentiated EC cells responsible for the early failure of the great 
majority of the P19-morula aggregation chimeras? 
It was difficult to prove that proliferating P19 EC cells were disrupting 
development very early following aggregation since no evidence for EC 
contribution to development was found. In a few cases, material recovered from 
resorption sites was run on gels, but very little debris was present and only AA 
isozyme was detected. This was probably maternal enzyme. Recovery of such 
small portions of debris was understandable following the histological 
examinations. They revealed that embryo development ceased very early and egg 
cylinders usually failed to develop. The few embryos which were recovered at 
5.5 or 6.5 days were normal and presumably non-chimeric. 
P19 cells, with a fairly short cell cycle time ~ vitro (about 12 hr) might 
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proliferate rapidly in the aggregates from the outset. There is increasing 
evidence that differentiation of EC cells is associated with a lengthening of 
the cell cycle, and that, specifically, a growth arrest must occur in Gl 
(Rosenstraus, ~ ~., 1982; Scott, ~ al., 1982). P19 cells may be less capable 
than Pl0 cells of leaving the proliferative phase and participating in 
development in a chimera. We must remember that EC cells have been selected for 
the property of continued proliferation, and feeder independent, fast-growing 
P19 cells seem to have adapted well to in vitro proliferation as stem cells. 
These cells may have lost much of the capacity to respond to the signals in the 
embryo which normally induce differentiation of pluripotent cells (Papaioannou 
and Rossant, 1983). Proliferating P19 cells may therefore disrupt the 
development of the embryo very early, preventing even egg cylinder formation. 
The recovery of a few normal, non-chimeric embryos from P19-morula aggregates is 
curious. Perhaps these cases reflect the tendency of P19 cells to form less 
well integrated aggregates. P19 cells injected into trophoblast vesicles die 
and only debris remains within the trophoblast a few days after transfer 
(Rossant and Papaioannou, in press). Similarly, if P19 cells do not integrate 
with the rCM of the embryo, they may die in these cases also. 
Fujii and Martin (1983) suggested that aggregation with morulae might 
represent a simple alternative to blastocyst injection for producing EC-embryo 
chimeras. Their aggregation chimeras also showed high EC contributions, and a 
high degree of abnormal development was seen in those chimeras, suggesting that 
high EC contributions were incompatible with normal development. But at the 
time of their study, very few euploid EC cell lines were available, and they, 
and Stewart (1982) also, had tested EC cells with known karyotypic 
abnormalities, the most serious of which was a lethal trisomy. The presence of 
this trisomy in a large proportion of the cells in the developing chimeric 
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embryos might have adversely affected their development. 
P19 cells retain a stable male diploid karyotype even with prolonged 
culture, and the only alteration noted to the normal Pl0 female karyotype has 
been the loss of an X-chromosome from some of the cells. That is, Pl0 cells 
sometimes acquire an XO genotype, with 39 chromosomes rather than the normal 
murine complement of 40 (G. Paterno and M. McBurney, unpublished). At the 
completion of this study, chromosome preparations were made from the Pl0 cells 
currently in culture. This culture had been maintained about two months, and in 
keeping with McBurney's observations, it was found to contain a mixture of cells 
with 39 or 40 chromosomes. The analysis of G-banded chromosomes in one spread 
containing 39 chromosomes indicated that the cells were XO. X-chromosome 
instability in cultured cells appears to be a rather common phenomenon. Not 
only are many EC cell lines XO, but pluripotent cells cultured directly from the 
embryo have also been shown to acquire the XO genotype with continued culture 
(Robertson ~ ~., 1983). Xo mice are healthy females which retain some 
fertility, although oogenesis is impaired (Burgoyne and Baker, 1981). While 
acquisition of the XO genotype might mitigate against germ line contribution, as 
Rossant has suggested (in preparation), it would seem very unlikely that this 
aberration was responsible for the gross developmental abnormalities seen in the 
chimeric embryos recovered in this study. 
Therefore, this study is the first in which the ability to form aggregation 
chimeras has been tested for EC cells without potentially deleterious 
chromosomal abnormalities. Furthermore, this study is the first in which the 
aggregation results could be compared to a complete set of results from 
blastocyst injections of the same EC cell lines. The results from the 
blastocyst injection studies suggested that a high EC contribution correlated 
with abnormal development. Aggregations of these same cell lines produced an 
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even higher rate of abnormal development, and in the case of P10 cells, it could 
be demonstrated that the abnormal embryos had very high EC contributions, 
strengthening the hypothesis considerably that high EC contribution is 
incompatible with normal development. It is possible, however, that at least 
some of the developmental difficulties encountered by EC-embryo aggregation 
chimeras might have been due to developmental asynchrony between the two cell 
types in the aggregates. This point will be considered in the next section. 
1~ 
II The behavior of ICM cells in aggregation chimeras 
Were the abnormalities characteristic of the EC-embryo chimeras due solely 
to the presence of a majority population of EC cells of tumor origin? EC cells 
appear to most closely resemble the pluripotent embryonic ectoderm of the late 
blastocyst and early egg cylinder and are clearly different from the blastomeres 
of the cleavage stage embryo. Therefore, when EC-morula aggregates were 
constructed, a mismatching of embryonic cell types was created. What are the 
effects of mismatching temporally asynchronous embryonic cell types on 
subsequent development? In order to create a control situation to 
test this question, aggregates had to be constructed which contained only 
normal, non-tumor derived embryonic cells, from different developmental stages. 
ICMs, isolated by immunosurgery from 3.5 day blastocysts, were aggregated with 
2.5 day morulae and these aggregates were tested for normal development in the 
parallel study to the EC-morula aggregations. 
The comparison of embryo recovery data (Table 22) revealed striking 
differences in the early resorption rates between P10 containing aggregates and 
ICM containing aggregates. P10 containing aggregates, even those containing 
three ICM-sized P10 clumps, implanted in the uterus and survived until 
midgestation at the same rate as transferred control morulae. However, when a 
single ICM (containing 15 or 20 normal embryonic cells) was aggregated with a 
morula, 62% of the embryos died and were resorbed prior to midgestation, a 
statistically significant difference in resorption rate. Unlike the P10 
experiments, in which no dose-response effect could be demonstrated by varying 
the numbers of P10 cells aggregated, the addition of three ICMs to a morula 
resulted in an even higher resorption rate (87%) such that embryo recovery at 
midgestation was very low. 
There have been other reports of low embryo recovery in similar types of 
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experiments. Fujii and Martin (1983) aggregated single ICMs with morulae and 
recovered embryos at a low rate (21 embryos/74 transferred = 28%). However, 
embryo loss was due to a failure of the embryos to implant, not to subsequent 
resorption, and control morulae implanted at the same inexplicably low rate 
(28%) in that study. Many of the embryos recovered were heavily chimeric and 
normal, while a few were somewhat retarded relative to the controls. While they 
conclude that they may have some evidence for altered development of aggregates 
containing embryo cells of different stages, this conclusion was not completely 
justified from their data. The results from this present study more 
convincingly demonstrate problems in development of these aggregates, due to 
embryo recovery rates significantly lower than controls and the recovery of one 
clearly abnormal embryo. 
Rossant has also noted low embryo recovery following aggregation of ICMs 
with morulae. In her first study, (1975) the implantation rates of these 
aggregates were consistently lower than the controls, and in two later studies 
(Rossant and Lis, 1979a and b) about half of the aggregate embryos resorbed 
early. Embryo recovery was considerably lower then, than that seen in her 
blastocyst injection experiments, but those data were not compared to recovery 
rates of transferred morula controls. This present study confirms this trend 
towards lower embryo recovery by making the comparison with controls, and by 
demonstrating a dose-response effect in the aggregations of three ICMs with a 
morula. 
Thirteen embryos escaped the early resorption effect following aggregation 
of an ICM with a morula. In this series of embryos, two major deviations from 
the embryos recovered after aggregating EC cells were seen. Unlike embryos 
recovered following aggregation of Pl0 cells, these embryos were all developing 
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normally. Unlike the normal embryos recovered following the aggregation of P19 
cells, many of these normal embryos were chimeric. In fact, the added ICM cells 
had totally directed the normal development of an embryo and its membranes in 
some cases. 
Three embryos only were recovered following aggregations of three ICMs with 
a morula. Two of these were normal and highly chimeric, but the third embryo, 
containing only normal, non-tumor derived cells, was clearly abnormal at 
midgestation. It exhibited abnormalities such as the poorly organised body and 
unfused allantois characteristic of Pi0 chimeras, suggesting that embryonic 
cells are capable of the same incomplete or inappropriate response to 
developmental signals in certain circumstances. 
Trace contributions of BB isozyme were seen in several ectoplacental cone 
fractions. While early ICM cells can colonize the trophectoderm in chimeras, no 
particular selection for early ICMs was made in these experiments, and these 
trace contributions are more likely to represent contamination by adherent 
membranes from the larger, more developed embryos recovered in these 
experiments. Correlating with this explanation is the observation that when the 
membrane fraction was not chimeric, no contribution to the epc was seen. 
In answer to the question raised at the beginning of this section, it was 
apparent that there were problems associated with the development of aggregate 
embryos containing only normal embryonic cells taken from different stages of 
development. However, the problems were not the same as those seen in the 
development of EC-morula aggregation chimeras, and it seems most unlikely that 
the developmental difficulties experienced by EC-morula aggregation chimeras 
were due solely to developmental asynchrony. 
Given that some normal ICM-morula aggregation chimeras could be recovered, 
why were so many of these embryos lost? Earlier stages of their development 
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were examined and compared to EC-morula aggregates at similar stages. It was 
noted that the addition of either ICM or EC cells to a morula delayed the onset 
of cavitation, but the effect was most marked in the P10 containing embryos. 
Eventually, these P10 containing embryos did develop into morphologically normal 
blastocysts in vitro. Interestingly, ICM containing embryos formed 
morphologically abnormal blastocysts in vitro. The appearance of these 
blastocysts suggested that the proliferation of the ICM cells was not 
regulated, such that blastocysts with disproportionately large rCMs, or 
blastocysts overgrown with rCM cells developed. While the formation of an 
improperly organized blastocyst could certainly account for the early failure of 
these embryos, these blastocysts had developed during a 48 hr in vitro culture 
period, while transferred embryos were maintained in vitro for 24 hr only and 
transferred usually as late morulae. When blastocysts which had developed from 
these late morulae were recovered from the uterus, the ICM cell proliferation 
appeared to have been regulated within the uterine environment, suggesting that 
the grossly abnormal blastocysts may have been ia ~ artifacts. Indeed, when 
the ~ ~ culture conditions were changed by varying the culture medium, 
normal blastocysts developed ~ vitro in Whitten's egg culture medium. Abnormal 
blastocysts had developed in another defined egg culture medium, and when the 
compositions of Whitten's and Brinster's media are compared, the greatest 
differences appear to be in the Na concentration, and in the amount of bovine 
serum albumin added. Brinster's medium contains 0.5% BSA vs 0.3% BSA in 
Whitten's, and Brinster's medium would have a higher osmolari t y due to both the 
higher Na and protein concentrations. Perhaps these are conditions which are 
more conducive to eventual excessive ICM cell proliferation in ~. 
Having seen the development of morphologically normal blastocysts from 
3ICM-morula aggregates ilL~ in Whitten's medium, this medium was substituted 
145 
fore< medium in the 24 hr in vitro culture period prior to transfer to determine 
if embryo recovery rates were improved. Previous to these experiments, 
Brinster's and Whitten's egg culture media had been tested for their ability to 
support in vitro embryo development. Both media allowed the development of 
blastocysts from embryos collected at the 8-cell stage, at a somewhat slower 
rate than that in~ medium. Whitten's medium appeared superior to Brinster's for 
the culture of embryos from the 2-cell stage. Following transfer of embryos 
cultured in Whitten's medium, control embryo recovery was comparable to that 
seen when the embryos were cultured in ~ medium prior to transfer. 
The recovery of four embryos following the transfer of 23 3ICM-morula 
aggregates cultured in Whitten's medium may represent an improvement over 
recovery of three embryos following transfer of 36 3ICM-morula aggregates 
cultured in ~ medium. However, embryo loss was still very high, and another 
variable appears to have been introduced with the use of Whitten's culture 
medium. Embryo loss was due primarily to a failure of these aggregate embryos 
to implant in the uterus, a difficulty not shared by Whitten controls in this 
series of experiments, nor by aggregates cultured in ~ medium. It is 
interesting that in one of Rossant's earlier studies of ICM-morula aggregation 
chimeras (1975), the implantation rates of the aggregates were consistently 
somewhat lower than the control rates. These aggregates were cultured in a 
similar egg culture medium (M16), but usually for 4 hr only prior to transfer. 
These current results confirm the earlier finding, and the trend towards lower 
implantation appears to have been magnified by the longer in vitro culture 
period. 
Given that grossly abnormal blastocysts apparently do not develop from 
ICM-morula aggregates in the uterus, and that varying the in vitro culture 
conditions such that normal blastocysts develop in vitro does not "cure" these 
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aggregates with respect to 19 YiY9 embryo recovery, it seems unlikely that the 
formation of an improperly organised blastocyst was the overriding reason for 
early embryo failure. The histological examinations indicated that resorption 
of these rCM containing aggregate embryos occurred very early, before 6.5 days 
in the majority of cases. The histological examination of 5.5 day embryos did 
not reveal a recurring developmental defect, but established that a variety of 
deviations from normal development could be detected at this time. rn several 
cases, retardation was the only obvious deviation, but in light of the very 
low embryo recovery at midgestation, it would seem likely that some of these 
apparently normal but retarded embryos would not survive. Although both P19 and 
rCM containing aggregates fail in large numbers before midgestation, a 
difference in early development of these aggregates was noted, in that very 
little, if any egg cylinder development was seen in P19 implantation sites. 
To summarize, a comparison of rCM-morula and EC-morula aggregate embryo 
development revealed that abnormalities of development are not the same amongst 
the various aggregates examined. 
1. The in vitro tests of development indicated that EC-morula aggregates 
form normal blastocysts but that rCM-morula aggregates sometimes formed 
abnormal blastocysts, depending on the culture medium employed. 
2. The early post-implantation development of Pl0 containing embryos was 
the most normal amongst the various aggregate embryos. Abnormalities 
in egg cylinder development were more obvious for rCM-containing 
aggregates, while P19-containing aggregates usually did not reach even 
the early egg cylinder stage. 
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3. By midgestation, the greatest differences amongst the embryos were 
seen. Pl0 containing embryos survived until midgestation, but were 
grossly abnormal. Most P19-morula aggregates did not survive until 
midgestation. The embryos recovered at midgestation were normal and 
non-chimeric. rCM containing embryos also demonstrated a high 
resorption rate prior to midgestation, but in contrast to EC-morula 
aggregates, it was possible to recover some normal chimeric embryos 
from rCM-morula aggregates. 
An hypothesis will be now be proposed to try to explain the low survival 
rate of rCM-morula aggregates and the differences in outcome following 
aggregation of P19 and Pl0 cells with morulae. 
What happens to the rCM following aggregation? rCM cells, the inner cells 
of the blastocyst, acquire a set of surface properties distinct from outer cells 
(Ziomek and Johnson, 1980 and 1982) and these inner properties can be recognized 
by cleavage stage blastomeres (Surani and Handyside, 1983). These cells spread 
over the more adhesive rCM cells, and during formation of an aggregate, the rCM 
will eventually be engulfed by the blastomeres, and internalised (Kimber ~~, 
1982). Surani and Barton (1984) review these experiments, and point out that EC 
cells evoke the same responses. As Stewart demonstrated in his first 
aggregation experiments, EC cells are also internalised in EC-morula aggregates, 
and this has been confirmed recently by Lehtonen ~~. (1984). (rn these 
present studies, there was evidence that EC cells might differ in this regard, 
in that Pl0 cells appeared to form well integrated aggregate morulae and 
presumably were more readily internalised than P19 cells.) Surani and Barton 
suggest that the total number of cells inside an aggregate determines whether 
further cells will be recruited from the still labile pre-blastocyst outer cell 
148 
population (the host cell population). A model of an aggregate, and certain 
predictions can be developed, following a consideration of Barton and Surani's 
hypothesis. 
aggregation of an reM or EC 
clump with a morula 
cross section through a hypothetical 
aggregate at the late morula stage 
rn the cross section through a hypothetical rCM or EC-morula aggregate at 
the late morula stage, three cell populations would be expected. The rCM or EC 
clump has been internalised and is surrounded by host blastomeres (the black 
cells). The reM or EC clump consists of two cell populations, the outer cells 
(blue) and a small group of three to five inner cells (red) which, in the case 
of the rCM of a normal blastocyst, would give rise to the embryo, while the 
outer cells would give rise to the membranes. r would suggest that this model 
of an aggregate predicts that the added rCM or EC cells will give rise to the 
embryo and contribute substantially to its membranes even if the added reM cell 
population has not expanded very much in the initial period after aggregation. 
The probability that an outer host blastomere would be recruited not only to the 
inner compartment but to the already established inner compartment of the rCM 
(that is, to the red area) would seem rather low. Yet, the pattern of 
colonization of the 13 embryos recovered at midgestation following aggregation 
of a single rCM with a morula does not fit these predictions. Only two embryos 
were recovered which were totally rCM-cell derived. Six other embryos were true 
chimeras, indicating that at least one host blastomere was recruited to the 
inner compartment of the blastocyst. And, in one conceptus, the embryo was 
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entirely host derived while the membranes were chimeric. In four other 
conceptuses, the added ICM cells did not participate in development at all. 
Even when three ICMs were aggregated with a morula, host blastomeres still 
participated in development. These results seem quite peculiar when this model 
is considered. In Rossant's three previous papers, embryos derived totally from 
the added ICM were seen, but more than half of the chimeras recovered had very 
substantial host blastomere contributions, and a rather large number of 
non-chimeric, host derived embryos were recovered in those experiments. 
These observations on colonization of chimeras suggest that the ICM cells 
are not integrated into development to the degree that we would expect following 
aggregation such that host blastomeres are recruited for embryo development. 
The majority of the ICM containing aggregates die, apparently after reaching the 
early egg cylinder stage. Why do they not continue their development, giving 
rise to non-chimeric, normal embryos, if the added ICM cells are simply excluded 
from the developing embryo in most cases? The ICM cells have been exposed to 
the microenvironment in the 3.5 day blastocyst and have been "primed" to 
differentiate. Therefore, it is possible that the added ICM cells cannot 
reintegrate into the 2.5 day embryo. Instead, they may continue along their 
already determined pathway, seriously disturbing the cell-cell interactions in 
the morula, leading to early embryo failure in most cases. Sometimes though the 
proper interactions must be established in these aggregates such that 
development proceeds, giving rise to normal embryos which often are 
chimeric. 
One possible incompatibility between ICM and morula cells may be in gap 
junction formation. Communication, and metabolic cooperation between cells in 
an embryo are normally established via gap junction formation beginning at 
compaction. Unless gap junctions are established between the internalised ICM 
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cells and the host blastomeres in the aggregates, these cells might not interact 
properly with each other. The possible role of gap junction formation between 
cells in a chimera as a factor influencing subsequent development has been 
considered recently by Papaioannou (Papaioannou, Waters and Rossant, submitted). 
She found that both PIO and P19 cells formed functional gap junctions with rCM 
cells and also with the blastomeres of morulae in co-cultures, and therefore a 
difference in gap junction formation (and communication) between these cells 
cannot explain the subsequent differences in development of these chimeras. Do 
gap junctions form between the cells in rCM-morula aggregation chimeras? A 
careful electron microscopic study of sectioned late aggregate morulae, such as 
the one described recently by Lehtonen et ai- (1984) in which EC-morula 
aggregates were examined, may be required to examine the interactions between 
these cells. 
Do EC cells behave differently than rCM cells in the aggregates during this 
initial early period? Unlike rCM cells, EC cells may not be committed to 
differentiation. They have been selected for the property of continued 
proliferation, and in the aggregate embryos, they may continue proliferation as 
stem cells. rn the case of P19 cells, this proliferation of stem cells is 
apparently -deleterious very early in development. PIO cells, however, may 
proliferate as stem cells initially, integrating with the cells of the morulae, 
and may then respond at least partially to the signals to differentiate. 
Eventually, if they constitute a high proportion of the embryo's cells, their 
inability to respond in a completely normal way to these signals leads to lethal 
disorganisation of the embryo. 
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III The effect of retinoic acid pretreatment on the ability of P19 cells to form 
chimeras 
Unlike P10-morula aggregation chimeras, P19-morula aggregation chimeras 
failed very early, apparently due to the persistence of undifferentiated stem 
cells. Following the injection of even a single P19 cell into a blastocyst, 
chimeras with tumors were recovered, again suggesting that persistence of stem 
cells, uncommitted to differentiation, is a problem with P19-embryo chimeras. 
Retinoic acid is known to commit P19 cells to differentiation in Yi!!Q. Would a 
retinoic acid" pretreatment of the P19 cells commit them to differentiate in vivo 
and perhaps then to participate in more normal development in chimeras? 
Published protocols for RA teatment of P19 cells specify a pretreatment time of 
48 hr to 5 days prior to assessment of differentiation in vitro. P19 cells 
treated 48 hours with retinoic acid would not aggregate with morulae, suggesting 
that changes in the surface properties of these cells had already occurred. 
Following a 24 hr pretreatment with RA, aggregations were successful, and embryo 
recovery was somewhat improved, but these embryos were still non-chimeric. The 
most striking feature of these data, however, was the continued high rate of 
resorption. Did undifferentiated EC cells persist in the embryos despite 
retinoic acid pretreatment? 
Examinations of cell cultures plated out after retinoic acid treatment, 
and of blastocyst outgrowths following aggregation of RA treated P19 cells with 
morulae suggested that EC cells persisted for at least 2 days in vitro even when 
a high degree of differentiation was evident in the cultures. Perhaps 
persistence of stem cells for this length of time in vivo was sufficient to 
severely disrupt early embryo development. The identifications of 
undifferentiated stem cells in the treated cultures were made initially on the 
basis of morphology, but additional autoradiographic analysis confirmed that 
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cells with an EC-like morphology in blastocyst outgrowths were not embryo 
derived. Finally, the immunofluorescence assays positively identified foci of 
undifferentiated EC cells amongst the differentiated cells present in cultures 
plated out after both 24 hr and 48 hr retinoic acid treatments. It seems 
likely, therefore, that undifferentiated EC cells persisted in P19-morula 
aggregates, even in those made with RA treated cells, and that they disrupted 
the development of these embryos. 
Although persistence of undifferentiated cells had been demonstrated 
in vitrQ following 48 hr RA treatment, the effect of the longer RA treatment was 
also tested in vivo, by blastocyst injection. The embryo recovery rate was very 
high but this marked improvement was most likely due to the switch to the 
blastocyst injection technique rather than to the longer drug treatment. In 
previous injections of P19 cells into blastocysts, embryo recovery at 
midgestation was high also (32/39 injected). Of those embryos, 69% were 
chimeras, and about half were obviously abnormal at 9.5 days. But following 
retinoic acid treatment, the embryos were normal and non-chimeric. Therefore, 
the RA treatment did not promote more normal differentiation, but seems only to 
have reduced stem cell proliferation following injection into blastocysts. In 
the chimeric embryo, stem cell proliferation normally may continue for some time 
prior to cell differentiation. Following retinoic acid treatment, the cells may 
differentiate immediately and inappropriately. For example, if neuronal 
precursors appear in a 4 or 5 day embryo, perhaps the embryonic environment is 
not conducive to their persistence. But do the cells differentiate in the 
blastocyst environment following RA induction? There was no evidence of P19 
cell differentiation in any of these experiments since chimeras were not 
recovered. Alternatively, the retinoic acid treatment may have reduced the 
proliferative capacity of the P19 cells, for example, such that they simply were 
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outgrown by the normal embryonic cells. Rosenstraus, etAl. (1982) have 
suggested that RA treatment of EC cells results in an increased generation time 
in vitro. 
These retinoic acid experiments have produced largely negative results, but 
have been useful as they represent the first tests of the drug's effects on EC 
cells in the ia YiYg embryonic environment. The drug has been tested in vivo 
for its effects on the process of epithelial carcinogenesis. rt has been 
reported that high doses of retinoids reduce the severity and incidence of 
lesions following a dose of an epithelial carcinogen (Hogan, 1979). Strickland 
and Sawey (1980) have reported some reduction in teratocarcinoma growth in Y1Y9 
after treatment of mice with retinoic acid. Histological analysis of the tumors 
as well as assays for endoderm marker enzymes suggested that retinoic acid was 
inducing differentiation of the EC cells in these tumors. While retinoic acid 
may eventually playa role in cancer therapy (though its toxic properties in 
high doses must be remembered) a question pertinent to this study is whether the 
retinoids playa role in normal embryogenesis, as suggested by McBurney 
(McBurney ~ Al., 1983). Strickland and Mahdavi, in their 1978 paper, suggested 
that experiments determining the effects of retinoic acid on blastocyst or rCM 
development in ~o would be pertinent, but reports of such experiments have 
not been found. Experiments in which early embryos were cultured in the 
presence of RA prior to injection of some or all of their rCM cells into 
blastocysts might provide an initial in vivo test of the drug's effects on 
embryogenesis. By tracing the pattern of colonization of chimeras by the 
treated rCM cells and comparing this to the widespread colonization of all 
embryonic tissues by normal injected rCM cells some insights into in-vivo RA 
effects might be gained. rt is possible though, that embryos die ~vitro on 
exposure to RA, or that the rCM cells would also be rendered incapable of 
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participating in development after RA pretreatment. Another approach might be 
to survey various embryonic cell cytosolic supernatant preparations for the 
presence of the RA cytoplasmic binding protein. If the retinoids do playa role 
in normal embryogenesis, we might expect that the cells of the early embryo 
would contain the binding protein. 
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Concluding remarks: Have EC-embryo chimeras fulfilled their potential? 
Papaioannou and Rossant also asked this question in their 1983 review. 
They pointed out that production of some healthy chimeras showed that EC cells 
were capable of participating in normal development . But this was true of only 
a few EC cell lines, and even with these cell lines, development was not always 
successful. It was clear that there were significant differences between the 
behavior of ICM cells and EC cells in blastocyst injection chimeras. This 
aggregation study, the first to utilize euploid cell lines, has magnified the 
difficulties experienced by these EC cells in reverting to a normal embryonic 
phenotype. In the case of Pl0 cells, this probably does not reflect some 
inherent lesser capacity for regulation by the morula than the blastocyst, 
but more probably reflects the effects of earlier association, and hence a 
greater chance of colonization of the embryo and participation in development. 
While limited EC outgrowth from blastocysts and the absence of tumors suggest 
limited Pl0 stem cell persistence in the embryonic environment, in the case of 
P19 cells the main problem may be resistance to the signals to differentiate. 
In the morula over proliferation of these stem cells may become a rather 
immediate problem for the embryo. When P19 cells are injected into blastocysts, 
conditions might prevail shortly thereafter which promote differentiation of at 
least some of the cells, albeit abnormally. 
The aggregations of ICM cells with morulae pointed out that there were 
difficulties associated with the development of these aggregates, containing 
temporally mismatched cells, but, nonetheless, some healthy chimeras were 
recovered. No healthy Pl0 or P19 chimeras, containing a predominant EC 
population have been recovered, either by injection or aggregation. 
As Papaioannou and Rossant state "the initial enthusiasm with which the 
(EC-embryo chimera) system was greeted must be tempered with a little caution". 
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EC cells have certainly been very useful in many types of in vitro studies, but 
it should be kept in mind that they cannot be considered the complete equivalent 
of normal embryonic cells. Regarding the use of EC cells as vehicles for the 
introduction of new genes into the mouse gene pool, production of germ line 
chimeras at high frequencies seems to be a remote possibility, especially since 
the heavily chimeric embryos (a prerequisite for a high probability of germ line 
colonization) recovered in this study were all abnormal, strongly supporting the 
hypothesis that high EC contributions are incompatible with normal development. 
Other techniques are becoming increasingly more feasible. Progress has been 
made with the technique of injecting DNA into eggs, as discussed by Papaioannou 
and Rossant, and the feasibility of using viral vectors by infecting morulae is 
currently under consideration in this laboratory. The development of 
pluripotent cultured cell lines directly from the embryo, avoiding tumor 
passage, is a promising alternative. 
Cultured EC cells are so far removed (via tumor passage and repeated 
cell culture passage) from the embryos from which they originated that they may 
have lost the ability to fully revert to a normal embryonic phenotype when 
returned to the embryonic environment. Presumably, cell cultures, established 
directly from blastocysts, without the intervening "black box" of the tumor 
passage step, might demonstrate preservation of more normal embryonic cell 
properties. Although Sherman (1975) concluded that the pluripotent embryonal 
type cells did not persist under the culture conditions employed initially, it 
has now become increasingly feasible, though still somewhat difficult, to 
establish cultures directly from the embryo, avoiding the tumor passage 
necessary to derive EC cells lines. Evans and Kaufman (1981), Martin (1981) and 
Axelrod (1984) have all successfully established pluripotent cell lines from 
blastocyst culture. Might these cells represent a better alternative to EC 
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cells as ~ ~ models of embryonic cells and vehicles for gene transfer? 
Again, the most stringent test of their normality would be their ability to 
colonize an embryo and differentiate normally in the chimera. 
Bradley et al. (1984) have recently published a report of successful 
chimera formation following injection of various embryo derived cultured cells 
into blastocysts. The cells colonized the embryos efficiently, and not only 
were the chimeras normal and tumor free, but several germ line chimeras were 
identified. Several properties of EC, ICM and these embryo derived cells 
(referred to as ES cells, for Embryo-derived Stem cells, by Rossant and 
Papaioannou, 1984) are compared in Table 23. 
These ES cells behaved more like ICM cells in the first blastocyst 
injection reports, and as more lines become available, they may replace EC cells 
in many studies if they maintain their normal karyotype and normal embryonic 
properties with continued in vitro proliferation. It would be most interesting 
to observe the development of ES-morula aggregation chimeras. This study 
predicts that if these cells closely resemble ICM cells, high early resorption 
might be seen, but some healthy, highly chimeric embryos should be recovered. 
Having adapted to in vitro culture, these cells may behave more like stem cells 
and might be more readily integrated into the morula, performing better than ICM 
cells in aggregation chimeras. If, on the other hand, they have acquired 
EC-like properties in in vitro culture, examples of abnormal development might 
be found at midgestation. 
Table 23 Properties of Pluripotent Cell Types 
In Vitro 
--
derivation by tumor passage 
feeder dependence 
differentiate spontaneously in vitro: 
a) to embryoid bodies 
b) to a variety of cell types 
normal karyotype 
In Vivo 
EC 
cells 
yes 
variable 
yes 
variable 
many 
aneuploid 
yes 
ES 
cells 
no 
yes 
yes 
yes 
yes oJ: 
ICM 
cells 
yes 
yes 
yes 
yes yes 
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tumorigenic 
tumor type teratocarcinomas 
blastocyst injection: 
survival of embryos to term following 
blastocyst injection (% injected) 
chimeras (% transferred) 
abnormal chimeras during gestation 
(i. chimeras) 
chimeras with tumors 
germ line colonization in 
chimeras (% bred) 
aggrega tion: 
survival of embryos to midgestation 
(% transferred) 
chimeras at midgestation 
(i. recovered) 
abnormal chimeras at midgestation 
(i. chimeras) 
13 to 58 
(Pl0) 
o to 57 
(Pl0) 
40 to 83 
(Pl0) 
yes 
very rare 
12.5 to 54 
(P19) (Pl0) 
o to 100 
(P19) (Pl0) 
58 to 100 
(Pl0) 
66 to 75 
44 to 60 
unknown 
no 
yes 
( 20i.) 
unknown 
unknown 
unknown 
80 
90 to 100 
no 
no 
common 
8 to 27 
(3ICMs) 
69 
6 
-I: except for modification to, or loss of an X-chromosome (Robertson ~!U:.:, 
1983) 
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SUMMARY: THE MAIN FINDINGS OF THIS STUDY 
1. Morula aggregation is an efficient method for producing EC-embryo chimeras. 
The results from the aggregations, when compared to previous blastocyst 
injection results, emphasize that diploid EC cell lines differ in their 
response to the embryonic environment, demonstrating varying capacities for 
normalisation and participation in embryonic development. 
2. Very high Pl0 contributions were achieved in aggregation chimeras. As in 
blastocyst injection chimeras, high Pl0 contributions were associated with 
abnormal development, suggesting that a majority population of normal 
embryonic cells must be present in a chimera to program normal development. 
Therefore, recovery of substantial numbers of germ line EC-embryo chimeras 
seems a remote possibility. 
3. P19 stem cell proliferation may disrupt development very early following 
aggregation since not even abnormal chimeras were recovered. Following 
blastocyst injection, these cells may respond partially to differentiation 
signals before stem cell proliferation has become totally disruptive. 
Eventually though, P19 cells disrupt normal embryo development following 
blastocyst injection also. 
4. There are problems associated with the development of ICM-morula aggregates, 
containing temporally mismatched cells. Most of these embryos failed around 
the early egg cylinder stage, and those which survived had lower ICM cell 
contributions than might have been expected, suggesting that ICM cells may 
not integrate into development in the morula environment. 
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5. While aggregates containing cells from different developmental stages 
experienced developmental problems, some healthy, highly chimeric 
embryos were recovered following aggregation of rCMs with morulae in 
contrast to the outcome of aggregating either Pl0 or P19 EC cells with 
morulae. Thus, EC-morula developmental abnormalities were not due to 
developmental asynchrony, but to deficiencies in response to developmental 
signals. 
6. Pretreatment with retinoic acid, which promotes differentiation over 
proliferation of EC cells in ~, did not promote recovery of healthy P19 
chimeras in vivo. P19 cells, treated 48 hours with RA, did not colonize the 
embryo following blastocyst injection, unlike untreated P19 cells. 
Differentiated cells either did not persist of perhaps did not even appear 
in these embryos. 
7. On the basis of both blastocyst injection and aggregation experiments, it 
may now be stated that EC cells do not possess the same developmental 
potential as rCM cells and are therefore not the complete equivalent of 
pluripotent embryonic cells. 
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APPENDIX 1 
PREPARATION OF MEDIA AND REAGENTS 
c::.<. MEM 
for 100 ml: 
88 ml c:>(. base (Gibco MEM c:::.( with glutamine, without nucleosides) 
1 ml streptomycin (stock: 5 mg/ml) 
1 ml penicillin (stock: 10,000 units/ml) 
5 ml fetal calf serum (Flow Labs., heat inactivated) 
5 ml newborn calf serum (Flow Labs., heat inactivated) 
The medium is filter sterilized through a Millipore filter, 0.4~pore size. 
Phosphate buffered saline (PBS) 
for 1 litre: 
100 mg CaC12 
200 mg KCl 
200 mg KH2P04 
59.2 mg MgS04 
8 g NaCl 
1.15 g Na2HP04 
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PBl 
stock solutions ml stock solution 
g/100ml for 104 ml PBl 
NaCl 0.9 68.96 
KCl 1.148 1.84 
Na2HP04 2.129 5.44 
KH2P04 2.096 0.96 
CaC12.2H20 1.617 0.88 
MgC12 3.131 0.32 
Na pyruvate 20 mg 22.40 
glucose 104 mg 
penicillin 10,000 units/ml 1.04 ml 
distilled H2O 2.16 ml 
phenol red 0.1 ml of 1'7. 
Add 10 ml fetal calf serum to 90 ml of this base and filter sterilize through a 
Millipore filter, 0.45~pore size. 
Acid Tyrode's Solution 
for 100 ml: 
0.8 g NaCl 
0.02 g KCl 
0.02 g CaC12.2H20 
0.01 g MgC12.6H20 
5.6 mg NaH2P04.2H20 
0.1 g glucose 
0.1 g NaHC03 
0.4 g polyvinyl pyrrolidone 
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This solution is adjusted to pH 2.5 and filter sterilized through a Millipore 
filter, 0.2)-'\ pore size. 
Avertin 
2.5 g 2,2,2-tribromoethanol is dissolved in 5 ml of tert-amyl alcohol then 
diluted to 200 ml with distilled H20 
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Tissu~matron processing series 
70% ethanol 1 hr at least 
70% ethanol 1 hr 
80% ethanol 1 hr 
90% ethanol 1 hr 
951. ethanol 1 hr 
absolute ethanol 1.5 hr 
absolute ethanol:xylene 1:1 1.5 hr 
xylene 1.5 hr 
xylene 1.5 hr 
wax* 1.5 hr 
wax 1.5 hr 
* paraffin wax, TissuePrep, Fisher Scientific 
Hematoxylin and Eosin Staining Series 
xylene, 5 min; xylene, 5 min; xylene/absolute ethanol 1:1, 2 min; absolute 
ethanol, 5 min; 95% ethanol, 2 min; followed by 1 min in each of 90%, 80%, 70%, 
50%, 30% ethanol; distilled H20, 1 min; hematoxylin, 6 min, followed by a 4 min 
wash in running water, then 1 min in each of 30%, 50%, 70% ethanol, then 30 sec 
in eosin followed by 1 min in each of 70%, 70%, 80%, 90% ethanol, then 
95% ethanol,2 min; absolute ethanol, 5 min; absolute ethanol:xylene 1:1, 5 min; 
xylene, 5 min; xylene, 5 min. 
Ehrlich's Alum Hematoxylin 
6 g Hematoxylin 
600 ml absolute ethanol 
60 ml acetic acid 
600 ml glycerol 
600 ml distilled H20 
200 g aluminum ammonium sulfate 
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The stain is aged at least 6 weeks, then filtered and diluted 1:2 with distilled 
H20 prior to use. 
Eosin 
1 g alcoholic eosin in 100 ml 80% ethanol 
1 g yellowish eosin in 100 ml H20 
1 g bluish eosin in 100 ml 30% ethanol 
Giemsa stock 
0.8 g Giemsa 
50 ml methanol 
50 ml glycerol 
Giemsa stain 
5 ml stock 
45 ml phosphate buffer (0.07M Na2HP04, 0.07M KH2P04, pH6.8) 
Fil ter. 
Preparation of egg culture media 
NaCl 
KCl 
KH2P04 
MgS04 
CaC12 
NaHC03 
glucose 
Na pyruvate 
Ca lactate 
Na lactate 
BSA 
penicillin 
streptomycin 
Whitten's 
mg/l00 ml 
514 
36 
16 
14.5 
140 
100 
2.5 
4.8 
0.37* 
300 
10,000 units 
5 
* ml 60% Na lactate syrup 
Notes: 
Brinster's 
mg/l00 ml 
554.6 
35.6 
16.2 
14.36 
18.9 
210.6 
100 
5.6 
0.375* 
500 
10,000 units 
5 
1. Phenol red (0.1 ml of a 1% solution) is added to the media. 
2. The pH is adjusted to 7.2 to 7.4 after gassing. 
3. The medium is usually prepared as a base, lacking BSA, and filter 
sterilized. 
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4. The BSA (bovine serum albumin) must be of high quality, such as Pentex 
Bovine Albumin, Fraction 5, Miles Laboratories. It is added to an aliquot 
of the base and thoroughly dissolved the day previous to use. 
5. After addition of the BSA to an aliquot, the complete medium is gassed, and 
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the pH checked for stability at pH 7.2 to 7.4. The medium is then filter 
sterilized through a Millipore filter, O.4~ pore size. 
6. The pyruvate and lactate should be of high quality, and fresh. 
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APPENDIX 2 STATISTICAL ANALYSES 
Question: Are the resorption rates of aggregates containing Pl0 or ICM cells 
significantly different from the control resorption rate in Table 1? 
The significance of these differences will be assessed by a calculation of ~~ 
from a 2 x 2 contingency table. 
Ho 1: There is no significant difference between resorption rates of control 
morulae and aggregates containing a single added ICM. 
Table 2 The observed results: Single ICM-morula aggregates 
Controls 
ICM-morula 
aggregates 
Totals 
Embryos 
80 
13 
93 
Resorptions Totals 
17 97 
21 34 
38 131 
The overall rate of resorption in these samples is 38/131 = 0.29. If these 
samples are drawn from 1 population, resorption should occur at an equal 
frequency in both samples ( that is, 0.29 x 97 and 0.29 x 34 = expected 
frequencies). 
TAB.LE 1 APPENDI X 2 
Descri]2tion Embryos 
of embryo transferred 
Control 128 morulae 
Aggregate: 
Pl0 clump + 41 
a morula 
Aggregate: 
3 Pl0 clumps + 31 
a morula 
Aggregate: 
single ICM + 48 
a morula 
Aggregate: 
3 ICMs + 36 
a morula 
EMBRYO RECOVERY DATA 
Implants 
(2rtransferred) 
Resor]2tions 
(~ im]2lants) 
97 (76%) 17 (17.5%) 
29 (71%) 7 (24%) 
23 (74%) 6 (26% ) 
34 (71%) 21 (62%) 
23 (64%) 20 (87%) 
Embryos 
( ~ implants) 
80 (82.5%) 
22 (76%) 
17 (74%) 
13 (J8%) 
3 (13%) 
..... 
'""-.J 
'""-.J 
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Table 3: The expected frequencies 
Embryos Resorptions Totals 
Controls 68.87 28.13 97 
rCM-morula 24.14 9.86 34 
aggregates 
Totals 93 38 131 
All column and row totals have been preserved in this calculation of expected 
frequencies. 
Table 4: Deviation of observed frequencies from expected frequencies 
(O-E values) 
Controls 
rCM-morula 
aggregates 
degrees of freedom 
where rx'2. = 10.83, 
where rx). 23.88, 
Embryos 
11.13 
-11.13 
in a 2 x 2 table 
P = 0.001 
p « 0.001 
Resorptions 
-11.13 
11.13 
1 
The high value for ~l indicates that the probability that deviations from 
expected frequencies occurred by chance alone is much less than 0.001, and 
therefore the differences between resor ption rates are significant. rCM 
containing aggregate embryos resorb at a significantly higher rate than control 
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embryos. Does increasing the number of rCM cells in the aggregate significantly 
increase the resorption rate? ?(~analysis is valid only if each category 
contains at least 5 entries. Because only 3 embryos were recovered, the 
3rCM-morula aggregate sample cannot be analysed alone, but has been combined 
with the single rCM-morula aggregate category. A short cut equation, 
eliminating the requirement for the calculation of expected frequencies, will be 
used for subsequent analyses (Bishop, 1966). 
Table 5: Observed results: rCM containing aggregates 
Embryos Resorptions 
Controls 80 17 
rCM containing 16 41 
aggregates 
Totals 96 58 
0(2 will be calculated from this short cut equation: 
'X'J..";. T"\ (oA. - 'oc. - ~h). ').. 
(Gtt+'c)C(:..-kk 'k---~c ;(b ,,"do) 
Totals 
97 
57 
154 
where the entries in the table are designated by the symbols given: 
Totals 
a b a + b 
c d c + d 
Totals a + c b + d a + b + c + d n 
n/2 is a correction factor for a discontinuous variable where the test assumes a 
continuous variable, and produces a value somewhat less than that calculated by 
the first method. 
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(The value for ~~ for single rCM-morula aggregates embryo recovery compared to 
controls, calculated from this equation is 21.825.) 
Calcula tion of l)(l from values in Table 5: 
~~-- \54 [l ~OX4\~_=-S \1 X 10) - '¥ J 2-
Q'7X $1><' gbx. 58 
42.974 
d.L = 1 
p = « 0.001 
The much higher value for ~lwhen the triple rCM-morula aggregate embryo 
recovery data is pooled with the single rCM-morula aggregate embyro recovery 
data indicates that the deviations from expected frequencies are much greater 
for this sample. An increase in the number of rCM cells in the aggregate is 
correlated with an increase in resorption rates. 
Question: Does the presence of Pl0 cells in the aggregate increase resorption 
rates? The embryo recovery rates are similar, by inspection, for the 2 groups 
of Pl0-morula aggregates. The data have been pooled and the ~2 value will be 
compared to recovery data for rCM containing aggregates. 
Table 6: Observed results: Pl0 containing aggregates 
Controls 
Pl0 containing 
aggregates 
Totals 
Embryos Resorptions Totals 
80 17 97 
39 13 52 
119 30 149 
12. = 14'1 [ (to)( \"~) -(~,q )/11) - \~ r 
~ 1 ><. 5"1..>< 1 \ q)( 30 
= 0.757 
d.f. = 1 
p = <0.50, >0.20 
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The variations in embryo recovery rates between controls and Pl0 containing 
aggregates would occur by chance less than 50% of the time but more than 20% of 
t he time. For rejection of Ho, a p value of 0.05 or less is desirable. The 
null hypothesis is not rejected. The presence of Pl0 cells in the aggregates 
pr obably does not significantly change the rate of embryo recovery at 
midgestation. 

